[go: up one dir, main page]

CN102002478A - Adipose-derived stem cell separation culture method - Google Patents

Adipose-derived stem cell separation culture method Download PDF

Info

Publication number
CN102002478A
CN102002478A CN 201010568873 CN201010568873A CN102002478A CN 102002478 A CN102002478 A CN 102002478A CN 201010568873 CN201010568873 CN 201010568873 CN 201010568873 A CN201010568873 A CN 201010568873A CN 102002478 A CN102002478 A CN 102002478A
Authority
CN
China
Prior art keywords
stem cells
cells
adipose stem
adipose
culturing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 201010568873
Other languages
Chinese (zh)
Other versions
CN102002478B (en
Inventor
田卫东
孙钦策
肖金刚
郭维华
李�杰
黄科
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu Worldlink Health Biotechnology Co ltd
Original Assignee
Sichuan University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sichuan University filed Critical Sichuan University
Priority to CN 201010568873 priority Critical patent/CN102002478B/en
Publication of CN102002478A publication Critical patent/CN102002478A/en
Application granted granted Critical
Publication of CN102002478B publication Critical patent/CN102002478B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

本发明公开了一种脂肪干细胞的分离培养方法。本发明的方法包括从脂肪组织中分离获取、培养SVF细胞,其特征在于还包括以下步骤:用免疫磁珠分选法除去SVF细胞中的Lin+细胞,获得Lin-细胞群;用流式细胞分选法从获得的Lin-细胞群中富集CD271+Sca-1+细胞,得到脂肪干细胞;将获得的脂肪干细胞用含有LIF、FGF2的培养基培养。本发明采用FACS和MACS相结合,可以高效快速的获得高纯度的脂肪干细胞,这群细胞具有较强的克隆形成能力、自我更新能力和多向分化潜能,本发明方法获得的P16代脂肪干细胞仍有较强的成脂能力和成骨能力,为在体外获取大量的具有干性的种子细胞运用于组织再生提供了新的方法。

Figure 201010568873

The invention discloses a method for separating and culturing fat stem cells. The method of the present invention comprises the steps of isolating, obtaining and culturing SVF cells from adipose tissue, and is characterized in that it also includes the following steps: removing Lin + cells in SVF cells by immunomagnetic bead sorting to obtain Lin- cell groups; The sorting method was used to enrich CD271 + Sca-1 + cells from the obtained Lin - cell population to obtain adipose stem cells; the obtained adipose stem cells were cultured with medium containing LIF and FGF2. The present invention uses the combination of FACS and MACS to efficiently and quickly obtain high-purity adipose stem cells. This group of cells has strong clone formation ability, self-renewal ability and multi-directional differentiation potential. The P16 generation adipose stem cells obtained by the method of the present invention are still It has strong adipogenic ability and osteogenic ability, and provides a new method for obtaining a large number of stem seed cells in vitro for tissue regeneration.

Figure 201010568873

Description

一种脂肪干细胞的分离培养方法A method for isolating and culturing fat stem cells

技术领域technical field

本发明涉及一种干细胞的分离培养方法,具体地说,是涉及一种采用荧光激活流式细胞分类和磁激活细胞分选相结合分离培养高纯度脂肪干细胞的方法。The invention relates to a method for separating and culturing stem cells, in particular to a method for separating and culturing high-purity fat stem cells by combining fluorescence-activated flow cytometry and magnetic-activated cell sorting.

背景技术Background technique

脂肪干细胞(Adipose-derived Stem Cells, ASCs),是目前广泛应用于组织工程及再生医学研究领域的一种成体干细胞(Cowan CM,.Nat Biotechnol, 2004. 22:560-567)。脂肪干细胞与骨髓间充质干细胞一样具有多向分化潜能,在特定条件下可以向脂肪细胞、成骨细胞、成软骨细胞、成肌细胞、成内皮细胞和成神经细胞等多个方向分化。除此之外,脂肪干细胞还具有许多其他类型成体干细胞所不具备的优势,如脂肪组织来源充足、取材方便、获取过程损伤轻微、无伦理学争议,平均每100 mL的脂肪组织中可获得约1×106个干细胞,脂肪组织来源的细胞约有2%具有干细胞特征,远高于骨髓间充质干细胞(bone marrow mesenchymal stem cells,BMSCs)(约0.02%的细胞具有干细胞特征)。并且脂肪干细胞具有稳定的群体倍增率、自我更新潜能及良好的免疫相容性(Strem BM,. Trends Biotechnol,2005.24:1246-1253 ),其基因转染效率高、能稳定表达外源基因,已广泛应用于再生医学的研究(Gimble JM,. Circ Res, 2007: 1249-1260)。而且ASCs分化为脂肪细胞的效率比BMSCs更高。因此,脂肪干细胞是组织工程研究理想的种子细胞之一,最有希望成为脂肪组织工程的种子细胞。Adipose-derived Stem Cells (ASCs) are a type of adult stem cells widely used in the research fields of tissue engineering and regenerative medicine (Cowan CM,. Nat Biotechnol, 2004. 22:560-567). Adipose stem cells, like bone marrow mesenchymal stem cells, have the same multidirectional differentiation potential, and can differentiate into adipocytes, osteoblasts, chondrocytes, myoblasts, endothelial cells, and neuroblasts under specific conditions. In addition, adipose stem cells also have many advantages that other types of adult stem cells do not have, such as sufficient sources of adipose tissue, convenient material collection, slight damage during the acquisition process, and no ethical disputes. On average, about 100 mL of adipose tissue can be obtained. For 1×10 6 stem cells, about 2% of cells derived from adipose tissue have stem cell characteristics, much higher than bone marrow mesenchymal stem cells (BMSCs) (about 0.02% of cells have stem cell characteristics). And adipose stem cells have a stable population doubling rate, self-renewal potential and good immune compatibility (Strem BM,. Trends Biotechnol, 2005.24:1246-1253), its gene transfection efficiency is high, and it can stably express foreign genes. It is widely used in the research of regenerative medicine (Gimble JM,. Circ Res, 2007: 1249-1260). Moreover, ASCs differentiate into adipocytes more efficiently than BMSCs. Therefore, adipose stem cells are one of the ideal seed cells for tissue engineering research, and are the most promising seed cells for adipose tissue engineering.

目前常用的脂肪干细胞分离培养方法是从脂肪组织分离获取细胞,经机械或酶处理方法分离除去红细胞等成熟细胞后,采用含10%胎牛血清的培养基进行继代培养。含10%胎牛血清的培养基虽可促进脂肪干细胞的增殖,但难以维持其未分化状态,使得继代培养的脂肪干细胞容易老化。机械或酶处理方法仅能除去红细胞等成熟细胞,除红后的这部分细胞实质为间质血管片段细胞(Stromal-vascular fraction ,SVF细胞),这部分细胞中仍含有大量成熟细胞,因而,现有获得的脂肪干细胞纯度不高,由于细胞的生长和细胞之间的信号交通有关,纯度不高的干细胞更易老化,往往在体外经5-6次传代培养脂肪干细胞后,脂肪干细胞就出现老化。干细胞老化(或称衰老),是指干细胞增殖能力下降,多向分化潜能(或称干性)降低或消失。老化意味着干细胞数量的减少和功能的减退,也可以说是无法再生。脂肪干细胞的老化限制了其在脂肪组织工程及其他组织工程中应用的深入研究。At present, the commonly used method of isolation and culture of adipose stem cells is to obtain cells from adipose tissue, and after mechanical or enzymatic treatment to remove mature cells such as red blood cells, the culture medium containing 10% fetal bovine serum is used for subculture. Although the medium containing 10% fetal bovine serum can promote the proliferation of adipose stem cells, it is difficult to maintain their undifferentiated state, making the subcultured adipose stem cells prone to aging. Mechanical or enzymatic treatment can only remove mature cells such as erythrocytes. After removing erythrocytes, the essence of these cells is stromal-vascular fraction cells (SVF cells), which still contain a large number of mature cells. Therefore, now The purity of the obtained fat stem cells is not high. Because the growth of the cells is related to the signal traffic between cells, the stem cells with low purity are more likely to age. Often, the fat stem cells will age after 5-6 subcultures in vitro. Stem cell aging (or senescence) refers to the decline in the proliferation ability of stem cells, and the reduction or disappearance of multidirectional differentiation potential (or stemness). Aging means the decrease in the number and function of stem cells, or the inability to regenerate. The aging of adipose-derived stem cells limits the in-depth study of its application in adipose tissue engineering and other tissue engineering.

目前分离纯化干细胞的方法有流式细胞分选法、免疫磁珠分选法等,例如In’t Anker 等运用流式细胞分选法从羊水中获得胎儿间充质干细胞,Coppi等运用免疫磁珠方法从羊水细胞中分离出AFS细胞(amniotic fluid stem cells,AFS)。但是这些对干细胞的体外分离技术大多是建立在对细胞表面标记识别的基础之上的,如Coppi等分离出的AFS细胞是c-Kit或CD117(干细胞因子受体)表达阳性的细胞,而各种成体干细胞有各自独特的标记物。Rodeheffer MS等用细胞流式分选(Fluorescent-activated cell sorting, FACS)从脂肪组织中分离到Lin-CD29+CD34+Sca-1+CD24+细胞群,但这群细胞只能向脂肪细胞分化,而且所得数量较低(0.08%±0.015))。到目前为止,脂肪干细胞的特异性标记还没有找到,还没有发现脂肪基质细胞(Adipose-derived stromal cells,ADSCs)里具有干性的细胞群,国内外的研究都不能获得高纯度的脂肪干细胞(高纯度脂肪干细胞指的是细胞表面抗原标志相同、具有均一性、自我更新和多向分化能力一致的一群脂肪组织来源的干细胞)。At present, methods for separating and purifying stem cells include flow cytometry and immunomagnetic bead sorting. AFS cells (amniotic fluid stem cells, AFS) were isolated from amniotic fluid cells by the bead method. However, most of these in vitro separation techniques for stem cells are based on the recognition of cell surface markers. For example, the AFS cells isolated by Coppi et al. are c-Kit or CD117 (stem cell factor receptor) positive cells, and each Each type of adult stem cell has its own unique markers. Rodeheffer MS et al. used cell flow sorting (Fluorescent-activated cell sorting, FACS) to separate the Lin - CD29 + CD34 + Sca-1 + CD24 + cell population from adipose tissue, but this group of cells can only differentiate into adipocytes, And the resulting numbers are low (0.08% ± 0.015)). So far, no specific markers of adipose-derived stem cells have been found, and no stem cell populations in adipose-derived stromal cells (ADSCs) have been found. Research at home and abroad cannot obtain high-purity adipose-derived stem cells ( High-purity adipose stem cells refer to a group of adipose tissue-derived stem cells with the same cell surface antigen markers, homogeneity, self-renewal and multidirectional differentiation capabilities).

现有分离的脂肪干细胞纯度不高、脂肪干细胞体外培养难以维持自我更新和多向分化潜能的问题,极大地限制了国内外研究结果之间的对比和重复。The existing isolation of adipose stem cells is not high in purity, and the in vitro culture of adipose stem cells is difficult to maintain self-renewal and multi-directional differentiation potential, which greatly limits the comparison and repetition of research results at home and abroad.

发明内容Contents of the invention

本发明的目的在于克服现有技术中体外培养条件下脂肪干细胞难以维持自我更新和多向分化潜能的不足,提供一种脂肪干细胞的分离培养方法及其有效的新培养基。经按照该方法分离培养脂肪干细胞,经10多代继代培养后脂肪干细胞仍可维持其自我更新和多向分化的潜能。The purpose of the present invention is to overcome the deficiency in the prior art that it is difficult for adipose stem cells to maintain self-renewal and multidirectional differentiation potential under in vitro culture conditions, and to provide a method for isolating and culturing adipose stem cells and an effective new medium thereof. After isolation and culture of adipose stem cells according to this method, the adipose stem cells can still maintain their self-renewal and multidirectional differentiation potential after more than 10 generations of subculture.

本发明实现上述发明目的的技术方案为:The technical scheme that the present invention realizes above-mentioned purpose of the invention is:

一种脂肪干细胞的分离培养方法,包括从脂肪组织中分离获取、培养SVF细胞,还包括用免疫磁珠分选法除去SVF细胞中的Lin+细胞,获得 Lin-细胞群;用流式细胞分选法从获得的Lin-细胞群中富集CD271+Sca-1+细胞,得到脂肪干细胞;将获得的脂肪干细胞用含有LIF、FGF2的培养基培养。A method for isolating and culturing adipose stem cells, comprising isolating and obtaining SVF cells from adipose tissue, culturing SVF cells, and removing Lin + cells in SVF cells by immunomagnetic bead sorting to obtain Lin- cell groups; The selection method enriches CD271 + Sca-1 + cells from the obtained Lin - cell population to obtain adipose stem cells; the obtained adipose stem cells are cultured with a medium containing LIF and FGF2.

上述脂肪干细胞的分离培养方法中,免疫磁珠分选法中所采用的标记物为CD5、CD45R、CD11b、Anti-Gr-1及Ter-119。In the above method for isolating and culturing adipose stem cells, the markers used in the immunomagnetic bead sorting method are CD5, CD45R, CD11b, Anti-Gr-1 and Ter-119.

上述脂肪干细胞的分离培养方法中,流式细胞分选法中使用的标记物为Lin、CD271和Sca-1。In the above method for isolating and culturing adipose stem cells, the markers used in the flow cytometry method are Lin, CD271 and Sca-1.

上述脂肪干细胞的分离培养方法中,培养获得的脂肪干细胞所用的培养基是含有LIF、FGF2的α-MEM培养基。In the above method for isolating and culturing adipose stem cells, the culture medium used for culturing the obtained adipose stem cells is an α-MEM medium containing LIF and FGF2.

上述脂肪干细胞的分离培养方法中,培养获得的脂肪干细胞所用的培养基是含有10%体积比胎牛血清、103-10U/mL LIF、10-100 ng/ mL FGF2的α-MEM培养基。In the above method for isolating and culturing adipose stem cells, the medium used for culturing the obtained adipose stem cells is α-MEM culture medium containing 10% by volume of fetal bovine serum, 10 3 -10 5 U/mL LIF, and 10-100 ng/mL FGF2 base.

上述脂肪干细胞的分离培养方法中,培养获得的脂肪干细胞所用的培养基是含有10%胎牛血清、103U/mL LIF、20 ng/mL FGF2的α-MEM培养基。In the above method for isolating and culturing adipose stem cells, the medium used for culturing the obtained adipose stem cells is α-MEM medium containing 10% fetal bovine serum, 10 3 U/mL LIF, and 20 ng/mL FGF2.

上述脂肪干细胞的分离培养方法中,还包括对获得的脂肪干细胞进行传代培养。The method for isolating and culturing the adipose stem cells above also includes subculture the obtained adipose stem cells.

上述脂肪干细胞的分离培养方法中,所述的传代培养是贴壁培养。In the above method for isolating and culturing adipose stem cells, the subculture is adherent culture.

上述脂肪干细胞的分离培养方法中,当获得的脂肪干细胞在培养皿底部的生长密度达70-90%时,进行传代培养。In the method for isolating and culturing adipose stem cells above, when the growth density of the obtained adipose stem cells reaches 70-90% at the bottom of the culture dish, subculture is carried out.

较好的,上述脂肪干细胞的分离培养方法中,当获得的脂肪干细胞在培养皿底部的生长密度达到80%时,进行传代培养。Preferably, in the above method for isolating and culturing adipose stem cells, subculture is performed when the growth density of the obtained adipose stem cells at the bottom of the culture dish reaches 80%.

上述脂肪干细胞的分离培养方法中,从脂肪组织中分离获取SVF细胞的过程为:在常规无菌条件下切取小鼠腹股沟脂肪垫,经漂洗、剪碎、除血液等处理后,在脂肪组织中加入与脂肪等体积的0.1%Ⅰ型胶原酶,经过消化、过滤、裂红、离心后所获得的细胞即为SVF细胞。In the above method for isolating and culturing adipose stem cells, the process of isolating and obtaining SVF cells from adipose tissue is as follows: cut out the mouse inguinal fat pad under conventional aseptic conditions, rinse, shred, remove blood, etc. Add 0.1% type Ⅰ collagenase equal to the volume of fat, and the cells obtained after digestion, filtration, red cracking and centrifugation are SVF cells.

上述脂肪干细胞的分离培养方法中,SVF细胞的培养采用含10%体积比胎牛血清的α-MEM培养基,培养条件为37℃、5%(v/v)CO2In the above-mentioned isolation and culture method of adipose stem cells, SVF cells were cultured using α-MEM medium containing 10% fetal bovine serum by volume, and the culture conditions were 37°C and 5% (v/v) CO 2 .

如前所述任意一项的脂肪干细胞的分离培养方法所分离培养的脂肪干细胞,用于纯化或克隆干细胞、转基因干细胞系的生产或者用于生产成脂/成骨细胞。The adipose stem cells isolated and cultured according to any one of the aforementioned methods for isolating and culturing adipose stem cells are used for the purification or cloning of stem cells, the production of transgenic stem cell lines, or the production of adipogenic/osteogenic cells.

如前所述脂肪干细胞用于生产成脂/成骨细胞的方法为:As mentioned above, the method of adipose-derived stem cells used to produce adipogenic/osteogenic cells is:

(1)、荧光激活流式细胞分类和磁激活细胞分选相结合分离获取ASCs;(1) ASCs were isolated and obtained by combining fluorescence-activated flow cytometry and magnetic-activated cell sorting;

(2)、将ASCs分别复合纤维蛋白和BCP支架材料,接种于裸鼠背部或小鼠股骨缺损处。(2) ASCs were respectively compounded with fibrin and BCP scaffold materials, and inoculated on the back of nude mice or the femoral defect of mice.

6-12周后,取出移植物进行HE切片染色、免疫组织化学检测等。After 6-12 weeks, the grafts were taken out for HE section staining and immunohistochemical detection.

现有技术中脂肪干细胞的传代培养容易出现老化,针对这一问题,发明人进行了广泛的研究,结果发现,将从脂肪组织中分离获取的SVF细胞用免疫磁珠分选法和流式细胞分选法相结合,可以尽可能地除去SVF细胞中的成熟细胞,由此可以获得抗原标志相同、具有均一性、自我更新和多向分化能力一致的高纯度脂肪干细胞。发明人比较了在培养基中加入抑制干细胞分化的因子LIF和促进干细胞增殖的因子FGF2和常规培养条件下的克隆形成能力、多向分化能力,结果发现在培养基中加入抑制细胞分化的因子LIF和促进干细胞增殖的生长因子FGF2可维持获得的高纯度干细胞的干性。In the prior art, the subculture of adipose stem cells is prone to aging. In view of this problem, the inventor has conducted extensive research and found that the SVF cells isolated from adipose tissue were sorted by immunomagnetic beads and flow cytometry. The combination of sorting methods can remove mature cells in SVF cells as much as possible, so that high-purity adipose stem cells with the same antigenic markers, homogeneity, self-renewal and multidirectional differentiation capabilities can be obtained. The inventors compared the ability of colony formation and multidirectional differentiation between the addition of the factor LIF that inhibits stem cell differentiation and the factor FGF2 that promotes the proliferation of stem cells in the culture medium, and the ability of multi-lineage differentiation, and found that adding the factor LIF that inhibits cell differentiation to the medium And the growth factor FGF2 that promotes the proliferation of stem cells can maintain the stemness of the obtained high-purity stem cells.

因此,本发明从脂肪组织中分离获取、培养SVF细胞脂肪,再从SVF细胞中采用MACS法去掉CD5+、CD45R+、CD11b+和Ter-119+这些造血和成熟细胞,富集Lin-细胞;然后采用FACS从Lin-细胞群中分选CD271、Sca-1表达阳性的细胞,富集CD271+Sca-1+细胞(即脂肪干细胞ASCs);获得脂肪干细胞后,通过在培养基中加入抑制细胞分化的因子LIF和促进干细胞增殖的生长因子FGF2来维持干细胞的干性。本发明比较了在培养基中加入抑制干细胞分化的因子LIF和促进干细胞增殖的因子FGF2和常规培养条件下的克隆形成能力、多向分化能力,证明了在培养基中加入LIF和FGF2,有助于维持脂肪干细胞的干性。本发明测定了ASCs的培养和克隆形成能力,并从形态学、免疫细胞化学、mRNA和蛋白水平等方面证实所获得的ASCs在体内和体外都具有多向分化潜能等功能。Therefore, in the present invention, SVF cells are isolated and cultured from adipose tissue, and then hematopoietic and mature cells such as CD5 + , CD45R + , CD11b + and Ter - 119 + are removed from SVF cells by MACS method, and Lin - cells are enriched; Then FACS was used to sort CD271 and Sca-1 positive cells from the Lin - cell population to enrich CD271 + Sca-1 + cells (that is, adipose stem cell ASCs); The differentiation factor LIF and the growth factor FGF2 that promotes stem cell proliferation maintain the stemness of stem cells. The present invention compares the clonogenic ability and multidirectional differentiation ability of adding the factor LIF which inhibits the differentiation of stem cells and the factor FGF2 which promotes the proliferation of stem cells in the culture medium and conventional culture conditions, and proves that adding LIF and FGF2 in the culture medium is helpful to maintain the stemness of adipose-derived stem cells. The present invention measures the culture and clone formation ability of ASCs, and confirms that the obtained ASCs have functions such as multi-directional differentiation potential in vivo and in vitro from aspects such as morphology, immunocytochemistry, mRNA and protein levels.

本发明采用FACS和MACS相结合,可以高效快速的获得高纯度的脂肪干细胞,与现有技术相比,本发明具有以下优点和积极效果:The present invention uses the combination of FACS and MACS to efficiently and quickly obtain high-purity adipose stem cells. Compared with the prior art, the present invention has the following advantages and positive effects:

1、本发明采用荧光激活流式细胞分类(FACS)和磁激活细胞分选(MACS)相结合的方法在国内外首次运用Lin-:CD271+:Sca-1+富集到高纯度的脂肪干细胞亚群,这群细胞具有较强的克隆形成能力、自我更新能力和多向分化潜能,而另外的细胞不具备有这种能力。1. The present invention adopts the method of combining fluorescence-activated flow cytometry (FACS) and magnetic-activated cell sorting (MACS) to enrich high-purity adipose-derived stem cells by using Lin - :CD271 + :Sca-1 + for the first time at home and abroad Subpopulation, this group of cells has strong clone formation ability, self-renewal ability and multi-lineage differentiation potential, while other cells do not have this ability.

2、本发明运用含有LIF和FGF2的条件培养基培养细胞,P16代脂肪干细胞仍有较强的成脂能力,P16代脂肪干细胞仍具有成骨的能力。2. The present invention uses the conditioned medium containing LIF and FGF2 to culture cells, and the P16 adipose stem cells still have a strong adipogenic ability, and the P16 adipose stem cells still have the osteogenic ability.

3、本发明运用纤维蛋白和双相磷酸钙陶瓷(BCP)作为脂肪干细胞的载体,采用绿色荧光蛋白转基因小鼠的ASCs作为示踪,证明了ASCs在体内成脂/成骨微环境中能转化为脂肪细胞和成骨细胞。3. The present invention uses fibrin and biphasic calcium phosphate ceramics (BCP) as carriers of adipose stem cells, and uses ASCs of green fluorescent protein transgenic mice as tracers to prove that ASCs can transform in the adipogenic/osteogenic microenvironment in vivo for adipocytes and osteoblasts.

4、本发明找到了一种可行、高效获得脂肪干细胞的方法,为在体外获取大量的具有干性的种子细胞运用于组织再生提供了新的方法。4. The present invention has found a feasible and efficient method for obtaining fat stem cells, which provides a new method for obtaining a large number of stem cells in vitro for tissue regeneration.

附图说明Description of drawings

图1为经过MACS获得的Lin-细胞群,然后用CD271和Sca-1两个抗体共染后流式细胞分选,得到Lin-:CD271+:Sca-1+细胞群(即脂肪干细胞)。Figure 1 shows the Lin - cell population obtained by MACS, and then co-stained with two antibodies CD271 and Sca-1 and then flow cytometrically sorted to obtain Lin - :CD271 + :Sca-1 + cell population (ie adipose stem cells).

图2为采用有限稀释法对ASCs进行克隆培养:其中 A为Lin-:CD271+:Sca-1+细胞群形成了克隆(第3天),Scale bars= 100μm; B为Lin-:CD271+:Sca-1+细胞群形成的克隆(第5天),Scale bars= 100μm。Figure 2 shows the clonal culture of ASCs using the limiting dilution method: where A is the Lin - :CD271 + :Sca-1 + cell population formed a clone (day 3), Scale bars= 100 μm; B is Lin - :CD271 + : Colony formed by Sca-1 + cell population (day 5), Scale bars = 100 μm.

图3 A、B为脂肪干细胞生长状态的光镜图,细胞为成纤维样梭形,可见典型漩涡状生长,其中A图的Scale bars= 40μm,B图的Scale bars=100μm。Figure 3 A and B are light micrographs of the growth state of adipose-derived stem cells. The cells are fibroblast-like spindle-shaped, with typical swirl-shaped growth. The Scale bars in A are 40 μm, and the Scale bars in B are 100 μm.

图4为 ASCs体外多向分化图,其中A:成脂诱导后,油红O将脂质染为橙红色, Scale bars= 200μm;B:成骨诱导分化后,茜素红染色显示钙结节为片状的红染,Scale bars= 100μm;C:成软骨诱导分化后,甲苯胺蓝染色显示软骨基质为蓝色,有软骨陷窝形成,Scale bars= 400μm;D:成肌诱导分化后,α-SMA免疫细胞化学染色为阳性,DAPI将细胞核染为蓝色,Scale bars= 400μm。Figure 4 is the multidirectional differentiation diagram of ASCs in vitro, in which A: After adipogenic induction, Oil Red O stains lipids in orange red, Scale bars= 200μm; B: After osteogenic differentiation, Alizarin red staining shows calcium nodules Scale bars= 100μm; C: After chondrogenic differentiation, toluidine blue staining showed that the cartilage matrix was blue, with cartilage lacuna formation, Scale bars= 400μm; D: After myogenic differentiation, α-SMA immunocytochemical staining was positive, DAPI stained cell nuclei in blue, Scale bars= 400 μm.

图5为 RT-PCR检测ASCs在成脂(PPARγ2、C/EBP-α、LPL)、成骨(Runx2、Opn)、成软骨(Acan、Sox9)和成肌(Myog、Myod1)诱导后,相关基因的表达情况,内参为GAPDH。结果显示,在经过多向诱导后,PPARγ2、C/EBP-α、LPL、Acan、Sox9、Myog、Myod1基因的表达水平升高,从mRNA水平充分说明了我们培养的脂肪干细胞能够向脂肪、骨、软骨、肌细胞方向分化。Figure 5 is the RT-PCR detection of ASCs after adipogenic (PPARγ2, C/EBP-α, LPL), osteogenic (Runx2, Opn), chondrogenic (Acan, Sox9) and myogenic (Myog, Myod1) induction, the correlation Gene expression, the internal reference was GAPDH. The results showed that after multidirectional induction, the expression levels of PPARγ2, C/EBP-α, LPL, Acan, Sox9, Myog, and Myod1 genes increased, which fully demonstrated from the mRNA level that our cultured adipose stem cells can promote fat, bone , cartilage, and muscle cell differentiation.

图6 FGF2和LIF对ASCs增殖能力的影响。加入FGF2和LIF的培养基维持了ASCs的快速增殖能力、稳定了细胞群体倍增时间;在无FGF2、LIF培养基的contorl组中,随着传代次数增多,细胞群体倍增时间延长。Figure 6 Effects of FGF2 and LIF on the proliferation ability of ASCs. The medium added with FGF2 and LIF maintained the rapid proliferation ability of ASCs and stabilized the doubling time of the cell population; in the contorl group without FGF2 and LIF medium, the doubling time of the cell population prolongs as the number of passages increases.

图7 为FGF2和LIF对ASCs的CFU-F形成能力的影响。FGF2和LIF培养基组CFU-F形成能力无明显下降;而无FGF2、LIF培养基的contorl组中CFU-F形成明显减少。Figure 7 shows the effects of FGF2 and LIF on the CFU-F formation ability of ASCs. The formation ability of CFU-F in the FGF2 and LIF medium groups did not decrease significantly; while the formation of CFU-F in the contorl group without FGF2 and LIF medium decreased significantly.

图8 为FGF2和LIF对维持ASCs成脂分化潜能的影响。A为FGF2和LIF培养基中的P16代ASCs成脂诱导10天后油红O染色结果,B为无FGF2和LIF培养的P16代ASCs成脂诱导10天后油红O染色结果,ASCs成脂能力明显降低,Scale bars= 200μm。Figure 8 shows the effects of FGF2 and LIF on maintaining the adipogenic differentiation potential of ASCs. A is the oil red O staining result of P16 ASCs in FGF2 and LIF medium after 10 days of adipogenic induction, B is the oil red O staining result of P16 ASCs cultured without FGF2 and LIF after 10 days of adipogenic induction, the adipogenic ability of ASCs is obvious Lower, Scale bars = 200μm.

图9甘油-3-磷酸脱氢酶活性定量测定。从P6代开始,有FGF2、LIF和无FGF2、LIF培养的ASCs两组间成脂诱导后甘油-3-磷酸脱氢酶活性出现明显差别,数据以mean±SE表示(n=3),(P﹤0.01)。Figure 9 Quantitative determination of glycerol-3-phosphate dehydrogenase activity. From the P6 generation, there was a significant difference in the glycerol-3-phosphate dehydrogenase activity between the two groups of ASCs cultured with FGF2, LIF and without FGF2, LIF after adipogenic induction, and the data were expressed as mean±SE (n=3), ( P﹤0.01).

图10 A:有FGF2和LIF的培养条件下,P16代ASCs成骨诱导后茜素红染色可见矿化结节形成;B:无FGF2和LIF的培养条件下,P16代ASCs成骨诱导后未见矿化结节形成。Scale bars= 100μm。Fig. 10 A: Under the culture condition of FGF2 and LIF, after osteogenic induction of P16 ASCs, the formation of mineralized nodules can be seen by alizarin red staining; B: Under the culture condition of no FGF2 and LIF, the formation of mineralized nodules of P16 ASCs after osteogenic induction See mineralized nodule formation. Scale bars = 100μm.

图11 C57小鼠的GFP脂肪干细胞为成纤维细胞样的梭形,胞内无脂滴,均有绿色荧光蛋白表达。图11A为普通光学显微镜的图像,图11B为倒置荧光显微镜观察到的图像。Scale bars= 40μm。Figure 11 The GFP adipose stem cells of C57 mice are fibroblast-like spindle-shaped, without lipid droplets in the cells, and all express green fluorescent protein. Figure 11A is an image of an ordinary optical microscope, and Figure 11B is an image observed by an inverted fluorescence microscope. Scale bars = 40μm.

图12细胞-纤维蛋白复合物植入体内6w后的成脂情况。A:HE染色显示,呈圆形或多边形,胞质内含有空泡,空泡为制作切片过程中被溶去脂滴的部位,胞核被脂滴挤向一侧、呈扁圆形,Scale bars=200μm。B:油红O染色显示,脂滴为橘红色,细胞核被挤到一边、呈蓝色,Scale bars=200μm。C:新生的脂肪细胞抗GFP免疫组织化学阳性,Scale bars=100μm。Fig. 12 Adipogenesis of the cell-fibrin complex 6 weeks after implantation in vivo. A: HE staining shows that it is round or polygonal, and contains vacuoles in the cytoplasm. The vacuoles are the parts where the lipid droplets are dissolved during the sectioning process. The nucleus is squeezed to one side by the lipid droplets, and it is oblate. bars=200μm. B: Oil red O staining shows that the lipid droplets are orange-red, and the nuclei are squeezed aside and appear blue, Scale bars=200μm. C: Anti-GFP immunohistochemistry of newborn adipocytes is positive, Scale bars=100μm.

图13细胞-BCP支架材料复合物植入体内后的成骨情况。A、B为HE和Masson染色,新骨主要在BCP支架材料的孔隙中形成,呈骨岛样分布,新骨周边是成骨细胞,HE染色可见淡粉红色的骨小梁及正在矿化的胶原纤维,可见到骨陷窝的形成;Masson染色可见新形成的骨小梁和正在矿化的胶原纤维为蓝色。Scale bars=200μm。C为新骨抗GFP免疫组织化学检测,其中浅棕色者为阳性细胞,可见成骨细胞抗GFP阳性(红色箭头所示)。Scale bars=200μm。Figure 13 Osteogenesis of the cell-BCP scaffold material composite implanted in vivo. A and B are HE and Masson staining. The new bone is mainly formed in the pores of the BCP scaffold material, and it is distributed like a bone island. The new bone is surrounded by osteoblasts. HE staining shows pale pink bone trabeculae and mineralizing bone Collagen fibers, the formation of bone lacuna can be seen; Masson staining shows the newly formed bone trabeculae and collagen fibers that are being mineralized in blue. Scale bars=200μm. C is anti-GFP immunohistochemical detection of new bone, in which light brown cells are positive cells, and osteoblasts are positive for anti-GFP (indicated by the red arrow). Scale bars=200μm.

具体实施方式Detailed ways

下面结合试验例及具体实施方式对本发明作进一步的详细描述。但不应将此理解为本发明上述主题的范围仅限于以下的实施例,凡基于本发明内容所实现的技术均属于本发明的范围。The present invention will be further described in detail below in conjunction with test examples and specific embodiments. However, it should not be understood that the scope of the above subject matter of the present invention is limited to the following embodiments, and all technologies realized based on the content of the present invention belong to the scope of the present invention.

本发明实施例中所提到的脂肪组织来源于小鼠,本发明实施例中所用主要材料、试剂与设备如下:The adipose tissue mentioned in the embodiments of the present invention is derived from mice, and the main materials, reagents and equipment used in the embodiments of the present invention are as follows:

C57小鼠(由四川大学华西医学实验动物中心提供);C57 mice (provided by the West China Medical Experimental Animal Center of Sichuan University);

绿色荧光蛋白转基因C57小鼠(生物治疗国家重点实验室干细胞生物学研究室惠赠);Green fluorescent protein transgenic C57 mice (gifted by the Stem Cell Biology Laboratory of the State Key Laboratory of Biotherapy);

裸小鼠(购自中国医学科学院实验动物研究所);Nude mice (purchased from the Institute of Experimental Animals, Chinese Academy of Medical Sciences);

纤维蛋白胶支架(杭州普济,中国);Fibrin glue scaffold (Hangzhou Puji, China);

多孔双相磷酸钙陶瓷(BCP)支架材料(由四川大学国家生物医学材料工程技术研究中心提供)。Porous biphasic calcium phosphate ceramic (BCP) scaffold material (provided by the National Engineering Research Center for Biomedical Materials, Sichuan University).

α-MEM培养基(Hyclone,美国);α-MEM medium (Hyclone, USA);

胎牛血清(Hyclone,美国);Fetal bovine serum (Hyclone, USA);

胰蛋白酶-乙二胺四乙酸(EDTA )(Gibco,美国);Trypsin-ethylenediaminetetraacetic acid (EDTA) (Gibco, USA);

FGF2(Peprotech Inc,美国);FGF2 (Peprotech Inc, USA);

LIF、Anti-GFP抗体(Millipore,美国);LIF, Anti-GFP antibody (Millipore, USA);

I型胶原酶(COLLAGENASE TYPE I),二甲基亚砜(DMSO),地塞米松(Dex),L-抗坏血酸(L-ascorbic acid),1, 25—二羟维生素D3(1, 25-(OH)2VitD3),3-异丁基-1-甲基黄嘌呤(IBMX),吲哚美辛,油红O,均购自美国Sigma公司;Type I collagenase (COLLAGENASE TYPE I), dimethyl sulfoxide (DMSO), dexamethasone (Dex), L-ascorbic acid (L-ascorbic acid), 1, 25-dihydroxyvitamin D3 (1, 25-( OH)2VitD3), 3-isobutyl-1-methylxanthine (IBMX), indomethacin, oil red O, all purchased from Sigma, USA;

RNA抽提试剂盒(上海华舜,中国);RNA extraction kit (Shanghai Huashun, China);

TaKaRa one step RNA PCR Kit (AMV)、DL2000均购自日本TaKaRa公司。TaKaRa one step RNA PCR Kit (AMV) and DL2000 were purchased from Japan TaKaRa Company.

恒温水浴箱(Heto-Hoten,丹麦);微量移液器(Gilson公司,法国);培养瓶(Corning,美国),电子天平(Strtorius,美国),0.22pm无菌针头式过滤器(Millipor,美国),超纯水机UNIQUE-R30(Millipore,美国);CO2培养箱(Thermo,德国,台式离心机 SORVALLR LEGEND RM(Thermo,德国),温控台式离心机 SORVALLR LEGEND T(Thermo,德国),Thermo KS12超净工作台(Thermo,德国),Thermo -86℃ HERA freeze, (Thermo,德国);OLYMPUS IX71倒置相差荧光显微镜(Olympus,日本),OLYMPUS CKX41倒置显微镜(Olympus,日本),OLYMPUS CX41正置显微镜(Olympus,日本),-152℃超低温冰箱(SANYO,日本),扫描电子显微镜(JSM-5900LV)(日本电子株式会社);Tanon-2500凝胶成像仪(上海天能,中国);PCR仪(BIO-RAD,美国),凝胶成象分析软件Quantity One 4.6.2(BIO-RAD,美国)。Constant temperature water bath (Heto-Hoten, Denmark); micropipette (Gilson Company, France); culture bottle (Corning, USA), electronic balance (Strtorius, USA), 0.22pm sterile syringe filter (Millipore, USA) ), ultrapure water machine UNIQUE-R30 (Millipore, USA); CO2 incubator (Thermo, Germany), tabletop centrifuge SORVALLR LEGEND RM (Thermo, Germany), temperature-controlled tabletop centrifuge SORVALLR LEGEND T (Thermo, Germany), Thermo KS12 ultra-clean bench (Thermo, Germany), Thermo -86℃ HERA freeze, (Thermo, Germany); OLYMPUS IX71 inverted phase-contrast fluorescence microscope (Olympus, Japan), OLYMPUS CKX41 inverted microscope (Olympus, Japan), OLYMPUS CX41 upright Microscope (Olympus, Japan), -152°C ultra-low temperature refrigerator (SANYO, Japan), scanning electron microscope (JSM-5900LV) (JEOL Ltd.); Tanon-2500 gel imager (Shanghai Tianneng, China); PCR instrument (BIO-RAD, USA), gel imaging analysis software Quantity One 4.6.2 (BIO-RAD, USA).

本发明列举的实施例中所述的脂肪干细胞的分离培养方法,包括从小鼠脂肪组织中分离获取、培养SVF细胞,还包括用免疫磁珠分选法除去SVF细胞中的Lin+细胞,获得 Lin-细胞群;用流式细胞分选法从获得的Lin-细胞群中富集CD271+Sca-1+细胞,得到脂肪干细胞;将获得的脂肪干细胞用含有LIF、FGF2的培养基培养并传代培养。The method for isolating and culturing adipose stem cells described in the examples cited in the present invention includes isolating, obtaining and culturing SVF cells from mouse adipose tissue, and also includes removing Lin + cells in SVF cells by immunomagnetic bead sorting to obtain Lin - cell population; CD271 + Sca-1 + cells were enriched from the obtained Lin - cell population by flow cytometry to obtain adipose stem cells; the obtained adipose stem cells were cultured and subcultured with a medium containing LIF and FGF2 .

上述脂肪干细胞的分离培养方法中,从小鼠脂肪组织中分离获取、培养SVF细胞包括,在常规无菌条件下切取小鼠腹股沟脂肪垫,经漂洗、剪碎、除血液处理后,在脂肪组织中加入与脂肪等体积的0.1%Ⅰ型胶原酶,经过消化、过滤、裂红、离心后所获得的细胞即为SVF细胞。In the above method for isolating and culturing adipose stem cells, isolating, obtaining and culturing SVF cells from mouse adipose tissue includes cutting out the inguinal fat pad of the mouse under conventional aseptic conditions, rinsing, shredding, and removing blood, and dissolving the SVF cells in the adipose tissue. Add 0.1% type Ⅰ collagenase equal to the volume of fat, and the cells obtained after digestion, filtration, red cracking and centrifugation are SVF cells.

SVF细胞的培养采用含10%胎牛血清的α-MEM培养基,培养条件为37℃、5%(v/ v)CO2SVF cells were cultured in α-MEM medium containing 10% fetal bovine serum, and the culture conditions were 37°C and 5% (v/v) CO 2 .

免疫磁珠分选法中所采用的标记物为CD5、CD45R、CD11b、Anti-Gr-1及Ter-119。流式细胞分选法中使用的标记物为Lin、CD271和Sca-1。The markers used in the immunomagnetic bead sorting method were CD5, CD45R, CD11b, Anti-Gr-1 and Ter-119. Markers used in flow cytometry were Lin, CD271 and Sca-1.

培养获得的脂肪干细胞所用的培养基是含有10%体积比胎牛血清、10U/mLLIF、20ng/mLFGF2的α-MEM培养基。The medium used for culturing the obtained adipose stem cells was α-MEM medium containing 10% by volume of fetal bovine serum, 10 3 U/mLLIF, and 20ng/mLFGF2.

进行贴壁传代培养,当获得的脂肪干细胞在培养皿底部的生长密度达80%时,进行传代培养,并将P16的脂肪干细胞,用于生产成脂/成骨细胞。Carry out adherent subculture, and when the growth density of the obtained adipose stem cells reaches 80% at the bottom of the culture dish, subculture is carried out, and the adipose stem cells at P16 are used to produce adipogenic/osteogenic cells.

1、间质血管片段(SVF)细胞的获取及培养:1. Acquisition and culture of stromal vascular fragment (SVF) cells:

1)取4周龄雌性C57小鼠,以戊巴比妥钠0.1mg/100g腹腔注射麻醉,麻醉显效后于无菌条件下取大鼠腹股沟脂肪垫,用无菌PBS溶液清洗组织块;1) 4-week-old female C57 mice were anesthetized by intraperitoneal injection of pentobarbital sodium 0.1mg/100g. After the anesthesia was effective, the inguinal fat pad of the rat was taken under aseptic conditions, and the tissue block was washed with sterile PBS solution;

2)在超净工作台中将脂肪组织块剪碎,用等体积0.1%Ⅰ型胶原酶于37℃恒温摇床上消化45-60 min,期间适当振荡以充分消化; 2) Cut the adipose tissue pieces into pieces in an ultra-clean workbench, and digest them with an equal volume of 0.1% type I collagenase on a constant temperature shaker at 37°C for 45-60 min, shaking properly during the period to fully digest;

3)加入含10%体积比胎牛血清的培养基中和Ⅰ型胶原酶,以70μm的细胞筛滤去未消化完全的较大组织块和消化余下的残渣,低速离心(1200g,5 min),离心管底部即为细胞团; 3) Add medium containing 10% fetal bovine serum by volume to neutralize type Ⅰ collagenase, use a 70 μm cell sieve to filter out undigested large tissue pieces and residues left after digestion, and centrifuge at low speed (1200g, 5 min) , the bottom of the centrifuge tube is the cell mass;

4)吸除表面漂浮的脂肪组织及成熟脂肪细胞,细胞团用新鲜配制的红细胞裂解液重悬并静置10 min,离心(300g,5 min);4) Aspirate the adipose tissue and mature adipocytes floating on the surface, resuspend the cell mass with freshly prepared erythrocyte lysate and let it stand for 10 min, then centrifuge (300g, 5 min);

5)收集离心管底部的细胞团(间质血管片段细胞,SVF细胞),培养基洗涤3次,按1×105/mL的细胞密度接种于直径10cm的培养皿中,在饱和湿度、37℃、5%CO2的孵箱中进行培养,每3天更换培养基,培养基为含100u/mL青霉素和100μg/mL链霉素的10%体积比FBS+α-MEM培养基;5) Collect the cell clusters (interstitial vascular fragment cells, SVF cells) at the bottom of the centrifuge tube, wash the medium three times, inoculate in a 10cm-diameter petri dish at a cell density of 1×105/mL, and store in saturated humidity at 37°C , 5% CO 2 incubator for cultivation, replace the medium every 3 days, the medium is 10% volume ratio FBS+α-MEM medium containing 100u/mL penicillin and 100 μg/mL streptomycin;

6)细胞在培养皿底单层生长达到约80%融合时,传代培养。6) When the cells grow in a monolayer at the bottom of the culture dish and reach about 80% confluence, subculture.

2、从SVF细胞中富集脂肪干细胞2. Enrichment of adipose stem cells from SVF cells

2.1获取SVF,选用Lineage Cell Depletion Kit阴选Lin-细胞:2.1 Obtain SVF and use Lineage Cell Depletion Kit to negatively select Lin - cells:

1)将得到的SVF细胞计数,PBS溶液洗,离心(300×g,10 min),完全吸除上清。1) Count the obtained SVF cells, wash with PBS solution, centrifuge (300×g, 10 min), and remove the supernatant completely.

2)40μL 缓冲液重悬107 个细胞。2) Resuspend 10 7 cells in 40 μL buffer.

3)加10μL Biotin-Antibody Cocktail于107细胞中。3) Add 10 μL Biotin-Antibody Cocktail to 10 7 cells.

4)充分混匀,4℃孵育10 min。4) Mix well and incubate at 4°C for 10 min.

5)加30μL 缓冲液于107细胞中。5) Add 30 μL buffer to 10 7 cells.

6)加20μL Anti-Biotin Microbeads。6) Add 20μL Anti-Biotin Microbeads.

7)充分混匀后4℃孵育15 min。7) Mix well and incubate at 4°C for 15 min.

8)1-2 mL 缓冲液洗细胞,离心(300×g,10 min),吸除上清。8) Wash the cells with 1-2 mL buffer, centrifuge (300×g, 10 min), and aspirate the supernatant.

9)重悬细胞在500μL 缓冲液中。9) Resuspend cells in 500 μL buffer.

10)将磁柱放于磁架的合适位置,500μL 缓冲液洗柱子一次。10) Put the magnetic column in a suitable position on the magnetic rack, and wash the column once with 500 μL buffer.

11)将500μL细胞悬液加于磁柱中,收集流出的液体,里面所含为Lin-细胞11) Add 500 μL of cell suspension to the magnetic column, collect the liquid that flows out, which contains Lin - cells

12)500μL 缓冲液洗磁柱3次,收集的流出液与上一步收集的流出液混在一起。12) Wash the magnetic column 3 times with 500 μL buffer solution, and mix the collected effluent with the effluent collected in the previous step.

13)移下磁柱,置于新的收集管上方,加1 mL 缓冲液于磁柱中,迅速推出磁性标记的细胞。此部所得细胞为Lin+细胞(CD5、CD45R、CD11b、Anti-Gr-1或Ter-119阳性)。13) Remove the magnetic column, place it on the top of a new collection tube, add 1 mL of buffer solution to the magnetic column, and quickly push out the magnetically labeled cells. The cells obtained in this section are Lin + cells (positive for CD5, CD45R, CD11b, Anti-Gr-1 or Ter-119).

2.2 FACS从Lin-细胞群中富集CD271+Sca-1+细胞2.2 FACS enrichment of CD271 + Sca-1 + cells from Lin - cell population

1)将上一步骤收集的Lin-细胞记数,置于1.5mL EP管中。1) Count the Lin - cells collected in the previous step and place them in a 1.5mL EP tube.

2)PBS液洗一次,用不含血清的α-MEM培养基重悬细胞。2) Wash once with PBS, and resuspend the cells with serum-free α-MEM medium.

3)加入purified的CD271一抗(兔抗小鼠),避光孵育30 min。3) Add purified CD271 primary antibody (rabbit anti-mouse) and incubate for 30 min in the dark.

4)PBS液洗,用不含血清的α-MEM培养基重悬细胞,加入荧光二抗(猴抗兔),孵育30 min。4) Wash with PBS, resuspend cells in serum-free α-MEM medium, add fluorescent secondary antibody (monkey anti-rabbit), and incubate for 30 min.

5)PBS液洗,用不含血清的α-MEM培养基重悬细胞,加入Sca-1和7AAD或DAPI,孵育30 min。5) Wash with PBS, resuspend the cells in serum-free α-MEM medium, add Sca-1 and 7AAD or DAPI, and incubate for 30 min.

6)PBS液洗,用不含血清的α-MEM培养基重悬细胞,上流式细胞仪无菌分选,得到Lin-:CD271+:Sca-1+的一群细胞及Lin-:CD271-和Lin-:CD271+:Sca-1-细胞群。6) Wash with PBS, resuspend the cells with serum-free α-MEM medium, and sort them aseptically on a flow cytometer to obtain a group of Lin - :CD271 + :Sca-1 + cells and Lin - :CD271 - and Lin - :CD271 + :Sca-1 - cell population.

7)得到的Lin-:CD271+:Sca-1+细胞群进行培养。同时,将收集的Lin+细胞群、Lin-:CD271-细胞群和Lin-:CD271+:Sca-1-细胞群也进行培养。7) The obtained Lin - :CD271 + :Sca-1 + cell population was cultured. At the same time, the collected Lin + cell population, Lin :CD271 cell population and Lin :CD271 + :Sca-1 cell population were also cultured.

3、ASCs克隆形成能力(Clony-forming unit-fibroblast,CFU-F)的测定3. Determination of ASCs clone forming ability (Clony-forming unit-fibroblast, CFU-F)

将新鲜分离的细胞群采用有限稀释方法进行克隆培养,用20%FBS+α-MEM培养基制成单个细胞的悬液,用微量吸管将单个的细胞吸入到48孔板的每个孔内,加入20%FBS+α-MEM培养基。The freshly isolated cell population was cultured by limiting dilution method, and a single cell suspension was made with 20% FBS+α-MEM medium, and a single cell was sucked into each well of a 48-well plate with a micropipette. Add 20% FBS+α-MEM medium.

14d后检测克隆形成情况,克隆形成率=(克隆形成/接种细胞数)×100%,经测定克隆形成率为15.7%±0.58,如图2所示细胞形成状态良好的克隆。After 14 days, the colony formation was detected. The colony formation rate=(cloning formation/number of inoculated cells)×100%. It was determined that the colony formation rate was 15.7%±0.58. As shown in Figure 2, the cells formed good clones.

4、ASCs体外多向分化能力的检测,此步骤是为了验证得到的脂肪干细胞的多向分化能力。4. Detection of multi-directional differentiation ability of ASCs in vitro, this step is to verify the multi-directional differentiation ability of the obtained adipose stem cells.

4.1成脂诱导4.1 Adipogenic induction

将P1代ASCs接种于六孔板中,24 h后加入成脂诱导液培养,诱导液成分见表1,每3天半量换液;成脂诱导10天后用4%多聚甲醛固定细胞,进行油红O染色,DAPI染核。如图4A所示,圆圆的脂滴呈红色,分布在细胞的周围,说明细胞能够向脂肪方向分化。The P1-generation ASCs were inoculated in six-well plates, and cultured in adipogenic induction medium after 24 h. Oil red O staining, DAPI staining nuclei. As shown in Figure 4A, the round lipid droplets are red and distributed around the cells, indicating that the cells can differentiate towards fat.

表1 各种诱导液配方Table 1 Formulas of various induction solutions

Figure 898892DEST_PATH_IMAGE001
Figure 898892DEST_PATH_IMAGE001

RT-PCR检测成脂诱导过程中成脂相关基因过氧化物酶体增殖体激活受体γ2 (peroxisome proliferator-activated receptor-γ2,PPARγ2) 、CCAAT增强子结合蛋白α (CCAAT/enhancer-binding α,C/EBP-α) 和脂蛋白酶(lipoprotein lipase, Lpl)的表达。参照上海华舜生物技术有限公司的RNA抽提试剂盒提取细胞总RNA, 然后按照TaKaRa One Step RNA PCR Kit(AMV)的操作说明合成cDNA, 将得到的cDNA模板-20℃贮存备用。根据待检测基因序列,采用Primer 5.0引物设计软件设计引物,以管家基因GAPDH作为内参。设计的正向引物 (Forward primer )、反向引物 (Reverse primer) 、退火温度 (annealing temperature,Tm) 和预期产物大小等见表2。如图5所示,细胞经脂向诱导后,脂肪细胞的特异性基因PPARγ2、C/EBP-α、Lpl的表达显著的增强,进一步从基因水平表明成脂分化成功。RT-PCR detection of adipogenesis-related genes peroxisome proliferator-activated receptor-γ2 (PPARγ2) and CCAAT enhancer-binding protein α (CCAAT/enhancer-binding α, C/EBP-α) and lipoproteinase (lipoprotein lipase, Lpl) expression. The total cellular RNA was extracted by referring to the RNA extraction kit of Shanghai Huashun Biotechnology Co., Ltd., and then cDNA was synthesized according to the operation instructions of TaKaRa One Step RNA PCR Kit (AMV), and the obtained cDNA template was stored at -20°C for later use. According to the gene sequence to be detected, primers were designed using Primer 5.0 primer design software, and the housekeeping gene GAPDH was used as an internal reference. The designed forward primer (Forward primer), reverse primer (Reverse primer), annealing temperature (annealing temperature, Tm) and expected product size are shown in Table 2. As shown in Figure 5, after the cells were induced to adipocytes, the expression of adipocyte-specific genes PPARγ2, C/EBP-α, and Lpl was significantly enhanced, which further indicated successful adipogenic differentiation from the gene level.

4.2成骨诱导4.2 Osteogenic induction

将P1代ASCs接种于六孔板中,24h后换成成骨诱导液培养,诱导液成分见表1,每3天换液。成骨诱导培养14d后将细胞爬片行茜素红染色,观察矿化结节的形成情况。如图4B所示,脂肪干细胞经骨向诱导后,分化为成骨细胞,有典型的红色钙结节形成。The P1-generation ASCs were inoculated in six-well plates, and replaced with osteogenic induction medium for culture after 24 hours. The composition of the induction medium is shown in Table 1, and the medium was changed every 3 days. After 14 days of osteogenic induction culture, the cell slides were stained with alizarin red to observe the formation of mineralized nodules. As shown in Figure 4B, after osteotropic induction, adipose-derived stem cells differentiated into osteoblasts, with typical red calcium nodules formed.

RT-PCR检测成骨培养过程中成骨相关基因Runt相关转录因子2/核心结合因子a1 (runt related transcription factor 2/ core binding factor a1,Runx2/Cbfal) 和骨桥蛋白(osteopontin,OPN)的表达。如图5所示,Runx2、OPN的表达显著升高,进一步从基因水平表明成骨分化成功。RT-PCR detection of osteogenesis-related genes Runt-related transcription factor 2/core binding factor a1 (runt related transcription factor 2/core binding factor a1, Runx2/Cbfal) and osteopontin (osteopontin, OPN) expression during osteogenic culture . As shown in Figure 5, the expressions of Runx2 and OPN were significantly increased, further indicating successful osteogenic differentiation at the gene level.

4.3成软骨诱导4.3 Chondrogenic induction

P1代ASCs以1×107/mL的细胞浓度重悬于1.2%低粘度的藻酸盐凝胶中,与100mM的CaCl2溶液交联,置于成软骨诱导液培养,诱导液成分见表1,每3天换液。成软骨诱导培养3周后将标本固定、切片后用甲苯胺蓝染色,观察软骨基质的形成。如图4C所示,脂肪干细胞经成软骨诱导后,甲苯胺蓝染色阳性,说明脂肪干细胞能够向软骨方向分化。P1 generation ASCs were resuspended in 1.2% low-viscosity alginate gel at a cell concentration of 1×107/mL, cross-linked with 100 mM CaCl2 solution, and cultured in chondrogenic induction medium. The composition of the induction medium is shown in Table 1. Change the medium every 3 days. After 3 weeks of chondrogenic induction, the specimens were fixed, sliced and stained with toluidine blue to observe the formation of cartilage matrix. As shown in FIG. 4C , the toluidine blue staining of the adipose-derived stem cells was positive after chondrogenic induction, indicating that the adipose-derived stem cells could differentiate toward cartilage.

RT-PCR检测成软骨相关基因SRY盒包含基因9(SRY-box containing gene 9,Sox9))和聚集蛋白聚糖(aggrecan,Acan)的表达。如图5所示,这2个软骨特异性的基因表达增强,进一步从基因水平表明成软骨分化成功。RT-PCR detected the expression of cartilage-related gene SRY box containing gene 9 (SRY-box containing gene 9, Sox9) and aggrecan (aggrecan, Acan). As shown in Figure 5, the expression of these two cartilage-specific genes was enhanced, further indicating the success of chondrogenic differentiation at the gene level.

4.4成肌诱导4.4 Myogenic induction

将P1代ASCs接种于六孔板中,24h后换成成肌诱导液培养,诱导液成分见表1(含50 μmol/L的氢化可的松,5%HS,10%FBS的DMEM/F12)。3周后4%多聚甲醛固定,α-SMA抗体免疫荧光染色。如图4D所示,平滑肌细胞特异性蛋白α-SMA的免疫细胞化学荧光染色呈阳性(绿色)。The P1-generation ASCs were inoculated in a six-well plate, and replaced with a myogenic induction medium for culture after 24 hours. ). After 3 weeks, the cells were fixed with 4% paraformaldehyde and immunofluorescence stained with α-SMA antibody. As shown in Figure 4D, immunocytochemical fluorescent staining for the smooth muscle cell-specific protein α-SMA was positive (green).

RT-PCR检测成肌细胞相关基因Myog和Myod1的表达。如图5所示,Myog和Myod1的表达量显著增高,从mRNA水平上进一步证实ASCs经成肌诱导后向成肌方向分化。The expression of myoblast-related genes Myog and Myod1 was detected by RT-PCR. As shown in Figure 5, the expression levels of Myog and Myod1 were significantly increased, which further confirmed that ASCs differentiated into myogenic direction after myogenic induction from the mRNA level.

待检测基因的引物序列如表2所示:The primer sequences of the genes to be detected are shown in Table 2:

表2 待测基因的引物及预期产物情况Table 2 Primers and expected products of the genes to be tested

 

Figure 2010105688734100002DEST_PATH_IMAGE003
 
Figure 2010105688734100002DEST_PATH_IMAGE003

注:PPAR-γ2:过氧化物酶体增殖体激活受体γ2; C/EBP-α: CCAAT增强子结合蛋白α;Lpl:脂白酶;Runx2:Runt相关转录因子2;Opn:骨桥蛋白;Sox9:SRY盒包含基因9;Acan:聚集蛋白聚糖;GAPDH:甘油醛-3-磷酸脱氢酶。Note: PPAR-γ2: peroxisome proliferator-activated receptor γ2; C/EBP-α: CCAAT enhancer-binding protein α; Lpl: lipoproteinase; Runx2: Runt-related transcription factor 2; Opn: osteopontin ; Sox9: SRY box containing gene 9; Acan: aggrecan; GAPDH: glyceraldehyde-3-phosphate dehydrogenase.

5、加入FGF2和LIF对ASCs增殖和多向分化能力的影响5. The effect of adding FGF2 and LIF on the proliferation and multilineage differentiation ability of ASCs

5.1 FGF2和LIF对ASCs增殖能力的影响5.1 The effect of FGF2 and LIF on the proliferation ability of ASCs

1)将ASCs分为无FGF2和LIF组和有FGF2和LIF组,FGF2和LIF组在10% FBS(v/ v)+α-MEM培养基中加入20 ng/mL的FGF2和1000 units/mL的LIF。分别取两组中第1、6、11和16代的ASCs,以5×103/孔将细胞种入12孔板中,在2、4、6、8和10d分别取出加和未加FGF2、LIF的细胞,以MTT法检测细胞数目,绘制生长曲线,计算细胞的群体倍增时间。1) The ASCs were divided into groups without FGF2 and LIF and groups with FGF2 and LIF. In the FGF2 and LIF groups, 20 ng/mL FGF2 and 1000 units/mL were added to 10% FBS(v/v)+α-MEM medium. The LIF. The ASCs of the 1st, 6th, 11th and 16th passages in the two groups were respectively taken, and the cells were planted into a 12-well plate at 5×103/well, and the ASCs with and without FGF2, For LIF cells, the cell number was detected by MTT method, the growth curve was drawn, and the population doubling time of the cells was calculated.

2)以10个/cm2接种细胞,14 d后分别检测有和无FGF2、LIF两组中的克隆形成情况,计算克隆形成率。2) Cells were inoculated at 10 cells/cm 2 , and 14 days later, the colony formation in the groups with and without FGF2 and LIF were detected, and the colony formation rate was calculated.

5.2 FGF2和LIF对维持ASCs多向分化潜能的作用5.2 The role of FGF2 and LIF in maintaining the multilineage differentiation potential of ASCs

5.2.1 对成脂分化潜能的影响5.2.1 Effect on adipogenic differentiation potential

分别取两组中第1、6、11和16代的ASCs,以相同的密度接种细胞。24h后加入成脂诱导液培养,成脂诱导10天后进行油红O染色。通过甘油-3-磷酸脱氢酶(glycerol-3-phosphate dehydrogenase,GPDH)活性测定判断脂肪细胞形成量,GPDH活性测定方法参考Hauner等报道的方法:PBS洗目的细胞,预冷的包含1 mM EDTA的25 mM Tris-HCl缓冲液收集细胞(pH 7.5),超声裂解细胞后取上清,紫外分光光度计检测GPDH活性,反应体系:100 mM三乙醇胺HCl 缓冲液(pH 7.5)、2.5 mM EDTA、0.12mM NADH、0.1 mM巯基乙醇和0.2 mM磷酸二羟丙酮。The ASCs of the 1st, 6th, 11th and 16th passages in the two groups were taken respectively, and the cells were inoculated at the same density. After 24 hours, adipogenic induction medium was added for culture, and oil red O staining was performed 10 days after adipogenic induction. Glycerol-3-phosphate dehydrogenase (glycerol-3-phosphate dehydrogenase, GPDH) activity was used to determine the amount of adipocyte formation. The method of GPDH activity was determined by referring to the method reported by Hauner et al.: wash the target cells with PBS, pre-cooled containing 1 mM EDTA Cells were collected with 25 mM Tris-HCl buffer solution (pH 7.5), the supernatant was obtained after the cells were lysed by ultrasonic, and the activity of GPDH was detected by ultraviolet spectrophotometer. Reaction system: 100 mM triethanolamine HCl buffer solution (pH 7.5), 2.5 mM EDTA, 0.12 mM NADH, 0.1 mM mercaptoethanol, and 0.2 mM dihydroxyacetone phosphate.

5.2.2对成骨分化潜能的影响5.2.2 Effects on osteogenic differentiation potential

1)分别取两组中第1、3、6、11和16代的ASCs,以相同的密度接种细胞。24 h后加入成骨诱导液培养,14天后进行茜素红染色,观察矿化结节的形成情况。1) Take the ASCs of the 1st, 3rd, 6th, 11th and 16th passages in the two groups, and inoculate the cells at the same density. After 24 hours, osteogenic induction medium was added for culture, and Alizarin red staining was performed 14 days later to observe the formation of mineralized nodules.

2)将P1代ASCs一组行常规成骨诱导,另外一组在成骨诱导液中同时加入20 ng/mL的FGF2和1000 units/mL的LIF。分别在第4、7、14和21天提取总RNA,按照前述方法对成骨相关基因Runx2和Ocn进行检测。2) A group of P1 generation ASCs was subjected to conventional osteogenic induction, and 20 ng/mL of FGF2 and 1000 units/mL of LIF were added to the osteogenic induction solution of the other group. Total RNA was extracted on days 4, 7, 14, and 21, respectively, and osteogenesis-related genes Runx2 and Ocn were detected according to the aforementioned method.

3)按照与1)同样的分组,分别提取有或无FGF2和LIF培养的第1、3、6、11和16代的ASCs的总RNA,RT-PCR检测成骨早期相关基因Runx2的mRNA表达,判断其是否具有成骨潜能。3) According to the same grouping as in 1), the total RNA of ASCs at passages 1, 3, 6, 11, and 16 cultured with or without FGF2 and LIF were extracted, and the mRNA expression of the early osteogenesis-related gene Runx2 was detected by RT-PCR , to determine whether it has osteogenic potential.

结果表明在无FGF-2和LIF的培养条件下,ASCs培养到P16代,成骨诱导后未见矿化结节形成,而有FGF-2和LIF的培养条件下,ASCs培养到P16代仍可见到矿化结节形成。P1代ASCs在无FGF-2和LIF的成骨诱导培养基中,成骨早期基因Runx2在7~14天时表达量较高,21天时表达消失,成骨晚期标志性基因Ocn在第7天时出现表达,持续至21天。而含有FGF-2和LIF的成骨诱导培养基中,ASCs中的成骨早期基因Runx2在21天时仍有表达,而成骨晚期基因Ocn在诱导过程中一直没有表达。在有FGF-2和LIF的基础培养基中,ASCs在P16代时仍可以检测到成骨早期基因Runx2的表达;而无FGF-2和LIF的基础培养基中,ASCs在P16代时未能检测到Runx2的表达。The results showed that under the culture conditions without FGF-2 and LIF, ASCs cultured to P16 generation, no mineralized nodules were formed after osteogenic induction, while under the culture conditions of FGF-2 and LIF, ASCs cultured to P16 generation still remained Formation of mineralized nodules can be seen. In P1 generation ASCs in the osteogenic induction medium without FGF-2 and LIF, the expression level of the early osteogenic gene Runx2 was high at 7-14 days, the expression disappeared at 21 days, and the late osteogenic marker gene Ocn appeared at the 7th day Expression lasted up to 21 days. In the osteogenic induction medium containing FGF-2 and LIF, the early osteogenic gene Runx2 in ASCs was still expressed at 21 days, while the late osteogenic gene Ocn was not expressed during the induction process. In the basal medium with FGF-2 and LIF, the expression of the early osteogenesis gene Runx2 could still be detected in ASCs at passage P16; while in the basal medium without FGF-2 and LIF, ASCs could not detect the expression of the early osteogenic gene Runx2 at passage P16. Expression of Runx2 was detected.

6、GFP脂肪干细胞的获取及培养(同C57小鼠),此试验是为了获取标记有GFP的脂肪干细胞,进一步进行体内试验验证。6. Acquisition and culture of GFP adipose stem cells (same as C57 mice), this experiment is to obtain adipose stem cells labeled with GFP, and further conduct in vivo test verification.

1)采用与上述相同的方法从GFP转基因C57小鼠脂肪组织中富集Lin-:CD271+:Sca-1+ GFP脂肪干细胞群;1) The Lin - :CD271 + :Sca-1 + GFP adipose stem cell population was enriched from the adipose tissue of GFP transgenic C57 mice using the same method as above;

2)将获取的细胞按1×10/mL的细胞密度接种于直径10cm的培养皿中进行培养,10%FBS (v/ v)+α-MEM培养基(含FGF-2和LIF),在饱和湿度、37℃、5%CO2的孵箱中培养,每3天更换培养基。2) Inoculate the obtained cells in a 10cm-diameter petri dish at a cell density of 1×10 5 /mL for culture, 10% FBS (v/v)+α-MEM medium (containing FGF-2 and LIF), Culture in an incubator with saturated humidity at 37°C and 5% CO2 , and replace the medium every 3 days.

3)Lin-:CD271+:Sca-1GFP脂肪干细胞群的体外成脂分化3) In vitro adipogenic differentiation of Lin - :CD271 + :Sca-1 + GFP adipose stem cell population

将获得的P3代GFP脂肪干细胞以1×10cells接种在直径3.5cm的培养皿中,24 h后开始成脂诱导,脂向诱导培养基包含α-MEM基础培养基、10% FBS、1μM 地塞米松、10μM 胰岛素、0.5mM 3-异丁基-1-甲基黄嘌呤和0.2mM 吲哚美辛及100u/mL青霉素、100μg/mL链霉素。每3天半量更换包含α-MEM基础培养基和10% FBS (v/ v)的培养基。The obtained P3 generation GFP adipose stem cells were inoculated in a culture dish with a diameter of 3.5 cm as 1×10 5 cells, and adipogenic induction began after 24 h. The adipogenic induction medium contained α-MEM basal medium, 10% FBS, 1 μM Dexamethasone, 10 μM insulin, 0.5 mM 3-isobutyl-1-methylxanthine, 0.2 mM indomethacin, 100 u/mL penicillin, 100 μg/mL streptomycin. The medium containing α-MEM basal medium and 10% FBS (v/v) was replaced every 3 days in half.

RT-PCR检测成脂诱导过程中成脂相关基因PPARγ2和C/EBP-α的mRNA表达情况。脂向诱导10d后的GFP脂肪干细胞用油红O染色检测脂滴形成情况。RT-PCR was used to detect the mRNA expression of adipogenic related genes PPARγ2 and C/EBP-α during adipogenic induction. Oil red O staining was used to detect the formation of lipid droplets in GFP adipose-derived stem cells 10 days after lipid orientation induction.

4)Lin-:CD271+:Sca-1GFP脂肪干细胞群的体外成骨分化4) In vitro osteogenic differentiation of Lin - :CD271 + :Sca-1 + GFP adipose stem cell population

将P3代GFP脂肪干细胞接种于六孔板中,24 h后更换成骨诱导液培养,成骨诱导培养基包含α-MEM基础培养基、10% FBS、10mM β-磷酸甘油钠、10-8mol/L地塞米松、50μM 抗坏血酸和0.01μM 1, 25-二羟维生素D3及100u/mL青霉素、100μg/mL链霉素。P3 generation GFP adipose stem cells were seeded in six-well plates, and cultured in osteogenic induction medium after 24 h. The osteogenic induction medium contained α-MEM basal medium, 10% FBS, 10 mM β-sodium glycerophosphate, 10 -8 mol/L dexamethasone, 50 μM ascorbic acid and 0.01 μM 1, 25-dihydroxyvitamin D3, 100 u/mL penicillin, and 100 μg/mL streptomycin.

RT-PCR检测成骨培养过程中成骨相关基因Runx2和Ocn的表达。成骨诱导培养21d的细胞爬片行茜素红染色观察矿化结节的形成。RT-PCR was used to detect the expression of osteogenesis-related genes Runx2 and Ocn during osteogenesis culture. Alizarin red staining was performed to observe the formation of mineralized nodules on the slices of cells cultured for 21 days after osteogenic induction.

结果表明GFP脂肪干细胞表现为梭形的成纤维细胞样形态,6天左右达到80%~90%细胞融合,所有细胞的绿色荧光蛋白表达均为阳性。GFP脂肪干细胞成脂诱导后,其胞浆中形成的脂质用油红O染色来鉴定,脂质被染成橙红色,而对照组染色为阴性;通过RT-PCR检测,成脂诱导过程中成脂特异性基因PPARγ2和C/EBP-α的mRNA表达明显增强;证实GFP脂肪干细胞经成脂诱导后成功分化为脂肪细胞。GFP脂肪干细胞成骨诱导后21d的细胞爬片行茜素红染色,可观察到红色矿化物质的形成;RT-PCR检测成骨培养过程中成骨特异性基因Runx2和Ocn的表达;证实GFP脂肪干细胞经过骨向诱导后向成骨方向分化。The results showed that GFP adipose stem cells exhibited a spindle-shaped fibroblast-like morphology, 80%-90% cell confluence was achieved in about 6 days, and the expression of green fluorescent protein in all cells was positive. After adipogenic induction of GFP adipose stem cells, the lipids formed in the cytoplasm were identified by Oil Red O staining, and the lipids were stained orange-red, while the staining of the control group was negative; by RT-PCR detection, during the adipogenic induction The mRNA expression of adipogenic specific genes PPARγ2 and C/EBP-α was significantly enhanced; it confirmed that GFP adipose stem cells successfully differentiated into adipocytes after adipogenic induction. Alizarin red staining was performed on the cell slides of GFP adipose-derived stem cells 21 days after osteogenic induction, and the formation of red mineralized substances could be observed; RT-PCR detected the expression of osteogenic specific genes Runx2 and Ocn during osteogenic culture; confirmed GFP After osteotropic induction, adipose-derived stem cells differentiate into osteoblasts.

7、细胞-纤维蛋白复合物的构建及体内植入,此试验的作用是验证脂肪干细胞的体内成脂分化。7. Construction of cell-fibrin complex and implantation in vivo. The purpose of this experiment is to verify the adipogenic differentiation of adipose stem cells in vivo.

1)采用P3代GFP+的Lin-:CD271+:Sca-1+脂肪干细胞,以2 × 10cells/mL的密度与含有1μg FGF2的100μl纤维蛋白原溶液混合均匀。以Lin-:CD271-和Lin-:CD271+:Sca-1-细胞组作为对照。1) Use P3 GFP + Lin - :CD271 + :Sca-1 + adipose stem cells and mix evenly with 100 μl fibrinogen solution containing 1 μg FGF2 at a density of 2 × 10 7 cells/mL. Lin - :CD271 - and Lin - :CD271 + :Sca-1 - cells were used as controls.

2)无菌条件下,用3.5%的水合氯醛麻醉裸鼠。2) Under sterile conditions, nude mice were anesthetized with 3.5% chloral hydrate.

3)麻醉显效后,将1)中含细胞的纤维蛋白原溶液与100μL凝血酶溶液同时注入裸鼠背部皮下。3) After the anesthesia became effective, the fibrinogen solution containing cells in 1) and 100 μL thrombin solution were simultaneously injected subcutaneously on the back of the nude mice.

8、细胞-BCP支架材料复合物的构建及体内植入,此试验的作用是验证脂肪干细胞的体内成骨分化。8. The construction and in vivo implantation of the cell-BCP scaffold material composite. The purpose of this experiment is to verify the osteogenic differentiation of adipose-derived stem cells in vivo.

8.1 BCP支架材料的特点及细胞-BCP支架材料复合物的构建8.1 Characteristics of BCP scaffold material and construction of cell-BCP scaffold material composite

多孔双相磷酸钙陶瓷(Biphasic calcium phosphate ceramics,BCP)支架材料中羟基磷灰石(HA)与β-磷酸三钙(β-TCP)的比例为30:70,长5mm,直径1.5mm。采用H2O2微波发泡方法制孔,大孔空隙大小200~500 μm,孔之间贯通性好,大孔孔壁上有大量的十几到几十微米相互贯通的微孔。经超声清洗、高温蒸汽灭菌后备用。The ratio of hydroxyapatite (HA) to β-tricalcium phosphate (β-TCP) in the porous biphasic calcium phosphate ceramics (Biphasic calcium phosphate ceramics, BCP) scaffold material is 30:70, with a length of 5 mm and a diameter of 1.5 mm. The pores are made by H 2 O 2 microwave foaming method. The size of the macropores is 200-500 μm, and the pores are well connected. There are a large number of interconnected micropores in the wall of the macropores. After ultrasonic cleaning and high temperature steam sterilization, it is ready for use.

以5×106 cells/mL的密度将GFP脂肪干细胞接种在BCP支架材料表面。5天后将细胞-支架材料复合物用PBS冲洗2次,2.5%戊二醛4℃固定过夜;30%、50%、75%、85%、95%、100%体积分数酒精梯度脱水;脱水后浸泡在醋酸异戊酯中置换1 h;临界点干燥、喷金;扫描电镜检测。GFP adipose stem cells were seeded on the surface of the BCP scaffold material at a density of 5×10 6 cells/mL. After 5 days, the cell-scaffold complex was washed twice with PBS, fixed overnight at 4°C with 2.5% glutaraldehyde; 30%, 50%, 75%, 85%, 95%, 100% volume fraction alcohol gradient dehydration; after dehydration Soak in isoamyl acetate for replacement for 1 h; critical point drying, gold spraying; scanning electron microscope inspection.

8.2细胞-BCP支架材料复合物的体内植入8.2 In vivo implantation of cell-BCP scaffold composite

1)采用上述同样的方法构建GFP脂肪干细胞-BCP支架材料复合物,共4个样。以Lin-:CD271-和Lin-:CD271+:Sca-1-细胞组作为对照。1) Use the same method as above to construct GFP adipose stem cell-BCP scaffold material composites, a total of 4 samples. Lin - :CD271 - and Lin - :CD271 + :Sca-1 - cells were used as controls.

2)无菌条件下,用3.5%的水合氯醛麻醉8周龄雄性普通C57小鼠。2) Under sterile conditions, 8-week-old male common C57 mice were anesthetized with 3.5% chloral hydrate.

3)麻醉显效后,无菌条件下在股骨区做切口,钝性分离肌肉,暴露股骨。用低速电钻制备长5mm的股骨缺损。3) After the anesthesia is effective, an incision is made in the femoral area under sterile conditions, and the muscles are bluntly separated to expose the femur. A 5mm long femoral defect was prepared with a low-speed electric drill.

4)将GFP脂肪干细胞-BCP支架材料复合物植入骨缺损区、丝线固定。分层对位缝合。4) The GFP adipose stem cell-BCP scaffold composite was implanted into the bone defect area and fixed with silk thread. Layered registration stitching.

9、种植细胞-支架材料复合物的检测。9. Detection of planting cell-scaffold composites.

9.1细胞-纤维蛋白复合物的检测9.1 Detection of cell-fibrin complexes

1)复合物植入6w,过量麻醉处死实验动物,取出植入的细胞-纤维蛋白复合物,常规石蜡包埋、HE切片染色。1) 6 weeks after the complex was implanted, the experimental animals were sacrificed by overdose anesthesia, and the implanted cell-fibrin complex was taken out, routinely embedded in paraffin, and stained with HE sections.

2)冰冻切片油红O染色,步骤如下:2) Oil red O staining of frozen sections, the steps are as follows:

A 取出的新生物用10%中性甲醛固定过夜。A The removed new organisms were fixed overnight with 10% neutral formaldehyde.

B -25℃恒冷箱中冰冻切片,切片厚度10μm。B Frozen sections in a constant temperature box at -25°C, with a thickness of 10 μm.

C 60%异丙醇中稍洗。Wash in 60% isopropanol for a while.

D 油红O染液侵染10 min。D Infect with oil red O staining solution for 10 min.

E 流水冲洗5 min。E Rinse with running water for 5 min.

F 苏木素液浸染2 min。F Soak with hematoxylin solution for 2 min.

G 流水冲洗5 min,1% (v/ v)盐酸酒精分化。G Rinse with running water for 5 min, and differentiate with 1% (v/v) hydrochloric acid alcohol.

H 水洗10min至细胞核蓝化。Wash with H water for 10 min until the nuclei turn blue.

I  吸去周围多余水分,甘油明胶封片。I Absorb the excess water around, and seal the slide with glycerin gelatin.

3)抗GFP的免疫组织化学检测,步骤如下:3) Immunohistochemical detection of anti-GFP, the steps are as follows:

A 制作5μm厚的石蜡切片,60℃烘箱中24 h。A Make paraffin sections with a thickness of 5 μm, and place them in a 60°C oven for 24 h.

B 二甲苯10 min,更换二甲苯后再浸泡10 min。B xylene for 10 min, then soak for another 10 min after replacing the xylene.

C 无水乙醇5 min,95%、85%、75% (v/ v)乙醇各5 min。C Absolute ethanol for 5 minutes, 95%, 85%, and 75% (v/v) ethanol for 5 minutes each.

D 流水冲洗5 min。D Rinse with running water for 5 min.

E 3% (v/ v)H2O2室温孵育15 min,阻断内源性过氧化物酶的活性。E 3% (v/v) H 2 O 2 was incubated at room temperature for 15 min to block the activity of endogenous peroxidase.

F ddH2O浸泡3 min×3次,浸泡过程中在低速摇床上振摇。Soak in F ddH 2 O for 3 min x 3 times, and shake on a low-speed shaker during the soaking process.

G 加入抗原修复液,95℃水浴45 min。G Add antigen retrieval solution and bathe in water at 95°C for 45 min.

H 室温下冷却30 min。倒掉抗原修复液,ddH2O浸泡1 min。Cool at room temperature for 30 min. Pour off the antigen retrieval solution and soak in ddH2O for 1 min.

I 1% (v/ v)盐酸酒精分化3 sec。I 1% (v/v) hydrochloric acid alcohol differentiation 3 sec.

J 10% (v/ v)正常山羊血清封闭,室温孵育10 min。倒去血清,勿洗,滴加1:500的小鼠抗GFP的一抗,4℃过夜。J 10% (v/v) normal goat serum was blocked and incubated at room temperature for 10 min. Pour off the serum, do not wash, add 1:500 mouse anti-GFP primary antibody dropwise, overnight at 4°C.

K 37℃孵育45 min,PBS冲洗,5 min×3次。Incubate at K 37°C for 45 min, wash with PBS, 5 min×3 times.

L 滴加1:100的兔抗小鼠二抗,37℃孵育30 min,PBS冲洗,5 min×3次L drop 1:100 rabbit anti-mouse secondary antibody, incubate at 37°C for 30 min, wash with PBS, 5 min×3 times

M 滴加1:100辣根过氧化物酶复合物,37℃孵育30 min,PBS冲洗,5 min×3次。M Add 1:100 horseradish peroxidase complex dropwise, incubate at 37°C for 30 min, wash with PBS, 5 min×3 times.

N DAB显色,在显微镜下掌握染色程度,流水冲洗10 min。Develop color with NDAB, grasp the degree of staining under a microscope, and rinse with running water for 10 min.

O苏木精复染2min,1%(v/ v)盐酸酒精分化,流水冲洗10min。Counterstain with O hematoxylin for 2 minutes, differentiate with 1% (v/v) hydrochloric acid alcohol, and rinse with running water for 10 minutes.

P 脱水、透明,中性树胶封片,显微镜下观察。P Dehydrated, transparent, sealed with neutral gum, observed under a microscope.

9.2细胞-BCP支架材料复合物的检测9.2 Detection of cell-BCP scaffold composites

1)复合物植入6w,过量麻醉处死实验动物,取出植入的GFP脂肪干细胞-BCP支架材料复合物,37℃水浴中12% EDTA脱钙2w。制作5μm厚的石蜡切片,常规HE染色、Masson染色。1) The composite was implanted for 6w, and the experimental animals were killed by overdose anesthesia, and the implanted GFP adipose stem cell-BCP scaffold material composite was taken out, and decalcified with 12% EDTA in a 37°C water bath for 2w. Paraffin sections with a thickness of 5 μm were made and routinely stained with HE and Masson.

2)制作5μm厚的石蜡切片,行抗GFP的免疫组织化学检测。2) Make paraffin sections with a thickness of 5 μm, and perform immunohistochemical detection of anti-GFP.

结果表明植入裸鼠体内6w,取出的新生物呈黄白色,体积较植入时明显减小。经HE、油红O染色,证实新生物含脂肪组织。脂向诱导组的脂肪细胞量明显比未诱导组多。新形成的脂肪细胞抗GFP免疫组织化学检测阳性,表明为植入的GFP脂肪干细胞转化而来。The results showed that after 6 weeks of implantation in nude mice, the new organisms taken out were yellowish-white, and their volume was significantly smaller than that of implantation. After HE and Oil Red O staining, it was confirmed that the neoplasm contained adipose tissue. The amount of adipocytes in the lipotropic induced group was significantly more than that in the uninduced group. Newly formed adipocytes were positive for anti-GFP immunohistochemistry, indicating transformation from engrafted GFP adipose-derived stem cells.

GFP脂肪干细胞-BCP支架材料复合物植入C57小鼠股骨缺损区6w,取出的新生物经HE、Masson染色,证实有新骨形成。将组织切片行抗GFP免疫组织化学检测,可见其部分成骨细胞阳性,而另外的成骨细胞为阴性,表明植入的GFP脂肪干细胞部分转化为成骨细胞,参与新骨的形成。The GFP adipose stem cell-BCP scaffold material composite was implanted into the femoral defect area of C57 mice for 6 weeks, and the new organisms taken out were stained by HE and Masson, and new bone formation was confirmed. Anti-GFP immunohistochemical detection of tissue sections showed that some of the osteoblasts were positive, while the other osteoblasts were negative, indicating that the implanted GFP adipose stem cells were partially converted into osteoblasts and participated in the formation of new bone.

在本发明中,从形态学、免疫细胞化学、mRNA和蛋白水平等方面证明了获得的ASCs 具有自我更新能力和多向分化的潜能,克隆形成能力较强,并证实其在成脂/成骨的微环境下可以转化为脂肪细胞/成骨细胞。该方法建立了一种高效、快速获得高纯度ASCs的新方法,为在体外获取大量的具有干性的种子细胞并应用于组织再生提供了新途径。In the present invention, it has been proved that the obtained ASCs have self-renewal ability and multi-directional differentiation potential from the aspects of morphology, immunocytochemistry, mRNA and protein levels, etc., and the clone formation ability is strong, and it has been confirmed that it has the ability of adipogenic/osteogenic It can be transformed into adipocytes/osteoblasts under the microenvironment. This method establishes a new method for obtaining high-purity ASCs efficiently and quickly, and provides a new way for obtaining a large number of stem seed cells in vitro and applying them to tissue regeneration.

序列表sequence listing

<110>四川大学<110>Sichuan University

 the

<120>一种脂肪干细胞的分离培养方法 <120> A method for isolating and culturing adipose-derived stem cells

<160>16<160>16

 the

<210>1<210>1

<211>22<211>22

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:PPAR-γ2上游引物<223> Description of the artificial sequence: PPAR-γ2 upstream primer

 the

<400>1<400>1

  agaccactcgcattcctttgac22agaccactcgcattcctttgac22

 the

<210>2<210>2

<211>21<211>21

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:PPAR-γ2下游引物<223> Description of the artificial sequence: PPAR-γ2 downstream primer

 the

<400>2<400>2

     tgctttatccccacagactcg21tgctttatccccacagactcg21

 the

<210>3<210>3

<211>22<211>22

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:C/EBP-α上游引物<223>Description of artificial sequence: C/EBP-α upstream primer

 the

<400>3<400>3

     ggatggtttcgggtcgctggat22ggatggtttcgggtcgctggat22

 the

<210>4<210>4

<211>23<211>23

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:C/EBP-α下游引物<223>Description of artificial sequence: C/EBP-α downstream primer

 the

<400>4<400>4

     cacggcctgactccctcatctta23cacggcctgactccctcatctta23

 the

<210>5<210>5

<211>18<211>18

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Lp1上游引物<223> Description of the artificial sequence: Lp1 upstream primer

 the

<400>5<400>5

     gaggatggcaagcaacac18gaggatggcaagcaacac18

 the

<210>6<210>6

<211>18<211>18

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Lp1下游引物<223> Description of the artificial sequence: Lp1 downstream primer

 the

<400>6<400>6

     tgggttagccaccgttta18tgggttagccaccgttta18

 the

<210>7<210>7

<211>23<211>23

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Runx2上游引物<223> Description of the artificial sequence: Runx2 upstream primer

 the

<400>7<400>7

     actacccagccacctttacctac23actacccagccacctttacctac23

 the

<210>8<210>8

<211>22<211>22

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Runx2下游引物<223> Description of the artificial sequence: Runx2 downstream primers

 the

<400>8<400>8

     gtcagcgtcaacaccatcattc22gtcagcgtcaacaccatcattc22

 the

<210>9<210>9

<211>18<211>18

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Opn上游引物<223> Description of the artificial sequence: Opn upstream primer

 the

<400>9<400>9

     tggtgcctgacccatctc18tggtgcctgacccatctc18

 the

<210>10<210>10

<211>18<211>18

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Opn下游引物<223> Description of artificial sequences: Opn downstream primers

 the

<400>10<400>10

     gctgccctttccgttgtt18gctgccctttccgttgtt18

 the

<210>11<210>11

<211>20<211>20

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Sox9上游引物<223> Description of the artificial sequence: Sox9 upstream primer

 the

<400>11<400>11

     gctctactccaccttcactt20gctctactccaccttcactt20

 the

<210>12<210>12

<211>18<211>18

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Sox9下游引物<223> Description of the artificial sequence: Sox9 downstream primer

 the

<400>12<400>12

     ttctccaatcgtcctcca18ttctccaatcgtcctcca18

 the

<210>13<210>13

<211>22<211>22

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Acan上游引物<223> Description of the artificial sequence: Acan upstream primer

 the

<400>13<400>13

     atggaaaccagcacggagacac22atggaaaccagcacggagacac22

     ``

<210>14<210>14

<211>22<211>22

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:Acan下游引物<223>Description of artificial sequence: Acan downstream primer

 the

<400>14<400>14

     ccagcctcagggtaagcagaca22ccagcctcagggtaagcagaca22

     ``

<210>15<210>15

<211>18<211>18

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:GAPDH上游引物<223> Description of the artificial sequence: GAPDH upstream primer

 the

<400>15<400>15

     tcaacggcacagtcaagg18tcaacggcacagtcaagg18

     ``

<210>16<210>16

<211>18<211>18

<212>DNA<212>DNA

<213>人工序列<213> Artificial sequence

 the

<220><220>

<223>人工序列的描述:GAPDH下游引物<223>Description of artificial sequences: GAPDH downstream primers

 the

<400>16<400>16

     accagtggatgcagggat18accagtggatgcagggat18

Claims (10)

1.一种脂肪干细胞的分离培养方法,包括从脂肪组织中分离获取、培养SVF细胞,其特征在于还包括以下步骤:用免疫磁珠分选法除去SVF细胞中的Lin+细胞,获得 Lin-细胞群;用流式细胞分选法从获得的Lin-细胞群中富集CD271+Sca-1+细胞,得到脂肪干细胞;将获得的脂肪干细胞用含有LIF、FGF2的培养基培养。1. A method for isolating and culturing adipose stem cells, comprising isolating and obtaining SVF cells from adipose tissue, and cultivating SVF cells, characterized in that it also includes the following steps: removing Lin + cells in SVF cells by immunomagnetic bead sorting to obtain Lin- Cell population; CD271 + Sca-1 + cells were enriched from the obtained Lin - cell population by flow cytometry to obtain adipose stem cells; the obtained adipose stem cells were cultured with medium containing LIF and FGF2. 2.根据权利要求1所述的脂肪干细胞的分离培养方法,其特征在于:免疫磁珠分选法中所采用的标记物为CD5、CD45R、CD11b、Anti-Gr-1及Ter-119。2. The method for isolating and culturing adipose-derived stem cells according to claim 1, wherein the markers used in the immunomagnetic bead sorting method are CD5, CD45R, CD11b, Anti-Gr-1 and Ter-119. 3.根据权利要求1所述的脂肪干细胞的分离培养方法,其特征在于:流式细胞分选法中使用的标记物为Lin、CD271和Sca-1。3. The method for isolating and culturing adipose stem cells according to claim 1, wherein the markers used in the flow cytometry method are Lin, CD271 and Sca-1. 4.根据权利要求1所述的脂肪干细胞的分离培养方法,其特征在于:培养获得的脂肪干细胞所用的培养基是含有10%体积比胎牛血清、103-10U/mL LIF、10-100 ng/mL FGF2的α-MEM培养基。4. The method for isolating and culturing adipose stem cells according to claim 1, characterized in that: the medium used for culturing the obtained adipose stem cells contains 10% by volume of fetal bovine serum, 10 3 -10 5 U/mL LIF, 10 -100 ng/mL FGF2 in α-MEM medium. 5.根据权利要求4所述的脂肪干细胞的分离培养方法,其特征在于:培养获得的脂肪干细胞所用的培养基是含有10%体积比胎牛血清、10U/mL LIF、20 ng/mL FGF2的α-MEM培养基。5. The method for isolating and culturing adipose stem cells according to claim 4, characterized in that: the medium used for culturing the obtained adipose stem cells contains 10% by volume of fetal bovine serum, 10 3 U/mL LIF, 20 ng/mL α-MEM medium for FGF2. 6.根据权利要求1所述的脂肪干细胞的分离培养方法,其特征在于:还包括对获得的脂肪干细胞进行传代培养。6. The method for isolating and culturing adipose stem cells according to claim 1, further comprising subculturing the obtained adipose stem cells. 7.根据权利要求6所述的脂肪干细胞的分离培养方法,其特征在于:所述的传代培养是贴壁培养。7. The method for isolating and culturing adipose stem cells according to claim 6, characterized in that: said subculture is adherent culture. 8.根据权利要求7所述的脂肪干细胞的分离培养方法,其特征在于:当获得的脂肪干细胞在培养皿底部的生长密度达70-90%时,进行传代培养。8. The method for isolating and culturing adipose stem cells according to claim 7, characterized in that: subculture is carried out when the growth density of the obtained adipose stem cells at the bottom of the culture dish reaches 70-90%. 9.根据权利要求1-8任意一项脂肪干细胞的分离培养方法所分离培养的脂肪干细胞的应用,其特征在于其应用于纯化或克隆干细胞、转基因干细胞系的生产或者用于生产成脂/成骨细胞。9. The application of the adipose stem cells isolated and cultured according to any one of the adipose stem cell separation and culture methods of claims 1-8, is characterized in that it is applied to the production of purified or cloned stem cells, transgenic stem cell lines or for the production of bone cells. 10.根据权利要求9所述的脂肪干细胞的应用,其特征在于其应用于生产成脂/成骨细胞的方法为:10. the application of adipose stem cell according to claim 9 is characterized in that it is applied to the method for producing adipogenic/osteoblast: (1)、荧光激活流式细胞分类和磁激活细胞分选相结合分离获取ASCs;(1) ASCs were isolated and obtained by combining fluorescence-activated flow cytometry and magnetic-activated cell sorting; (2)、将ASCs分别复合纤维蛋白和BCP支架材料,接种于裸鼠背部或小鼠股骨缺损处。(2) ASCs were respectively compounded with fibrin and BCP scaffold materials, and inoculated on the back of nude mice or the femoral defect of mice.
CN 201010568873 2010-12-01 2010-12-01 Adipose-derived stem cell separation culture method Active CN102002478B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201010568873 CN102002478B (en) 2010-12-01 2010-12-01 Adipose-derived stem cell separation culture method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201010568873 CN102002478B (en) 2010-12-01 2010-12-01 Adipose-derived stem cell separation culture method

Publications (2)

Publication Number Publication Date
CN102002478A true CN102002478A (en) 2011-04-06
CN102002478B CN102002478B (en) 2013-01-02

Family

ID=43810180

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201010568873 Active CN102002478B (en) 2010-12-01 2010-12-01 Adipose-derived stem cell separation culture method

Country Status (1)

Country Link
CN (1) CN102002478B (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102485885A (en) * 2011-06-09 2012-06-06 臻景生物技术(上海)有限公司 Separating method and application of fat stem cells
CN103830275A (en) * 2012-11-21 2014-06-04 瑟弗维股份有限公司 Adipose tissue-derived stem cells for veterinary use
CN104630140A (en) * 2013-11-06 2015-05-20 吉林济惠生物科技有限公司 Isolation and culture method of placenta mesenchyma precursor stem cells
CN106337036A (en) * 2016-08-26 2017-01-18 杭州易文赛生物技术有限公司 A method for improving the extraction rate of CD34 positive vascular matrix components in adipose tissue
CN106399234A (en) * 2016-08-31 2017-02-15 肖锷 Processing method of adipose tissue, mesenchymal stem cell, single processed adipose cell, and extracellular matrix
CN107254435A (en) * 2017-06-08 2017-10-17 黎洪棉 A kind of internal construction method of study of vascularized tissue engineering fat flap
CN107345897A (en) * 2016-05-04 2017-11-14 上海米洋杨生物科技有限公司 A kind of screening technique of retinal photoreceptor cells specific surfaces albumen
CN109266601A (en) * 2018-07-12 2019-01-25 江苏瑞思坦生物科技有限公司 The method for constructing clinical fat stem cell bank
US10589268B2 (en) 2016-06-08 2020-03-17 The Regents Of The University Of California Method and device for processing tissues and cells
CN111040994A (en) * 2019-11-20 2020-04-21 中国人民解放军陆军军医大学第一附属医院 A method for efficiently isolating adipose-derived adipose-derived mesenchymal stem cells
US10683480B2 (en) 2013-06-21 2020-06-16 The Regents Of The University Of California Microfluidic tumor tissue dissociation device and method
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells
CN113215092A (en) * 2021-05-26 2021-08-06 山东博森医学工程技术有限公司 Rapid adipose-derived mesenchymal stem cell adipogenic differentiation method

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
《国际口腔医学杂志》 20080930 管晓光 脂肪基质细胞骨向诱导分化的研究进展 第35卷, 第5期 2 *
《实用口腔医学杂志》 20040131 陈希哲等 人体脂肪基质细胞分离培养及其成骨潜能 第20卷, 第1期 2 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102485885A (en) * 2011-06-09 2012-06-06 臻景生物技术(上海)有限公司 Separating method and application of fat stem cells
CN103830275A (en) * 2012-11-21 2014-06-04 瑟弗维股份有限公司 Adipose tissue-derived stem cells for veterinary use
US10683480B2 (en) 2013-06-21 2020-06-16 The Regents Of The University Of California Microfluidic tumor tissue dissociation device and method
US11427798B2 (en) 2013-06-21 2022-08-30 The Regents Of The University Of California Microfluidic tissue dissociation device and method
CN104630140A (en) * 2013-11-06 2015-05-20 吉林济惠生物科技有限公司 Isolation and culture method of placenta mesenchyma precursor stem cells
US10722540B1 (en) 2016-02-01 2020-07-28 The Regents Of The University Of California Microfluidic device and method for shear stress-induced transformation of cells
CN107345897A (en) * 2016-05-04 2017-11-14 上海米洋杨生物科技有限公司 A kind of screening technique of retinal photoreceptor cells specific surfaces albumen
US11130127B2 (en) 2016-06-08 2021-09-28 The Regents Of The University Of California Method and device for processing tissues and cells
US10589268B2 (en) 2016-06-08 2020-03-17 The Regents Of The University Of California Method and device for processing tissues and cells
CN106337036A (en) * 2016-08-26 2017-01-18 杭州易文赛生物技术有限公司 A method for improving the extraction rate of CD34 positive vascular matrix components in adipose tissue
CN106399234A (en) * 2016-08-31 2017-02-15 肖锷 Processing method of adipose tissue, mesenchymal stem cell, single processed adipose cell, and extracellular matrix
CN107254435A (en) * 2017-06-08 2017-10-17 黎洪棉 A kind of internal construction method of study of vascularized tissue engineering fat flap
CN109266601A (en) * 2018-07-12 2019-01-25 江苏瑞思坦生物科技有限公司 The method for constructing clinical fat stem cell bank
CN111040994A (en) * 2019-11-20 2020-04-21 中国人民解放军陆军军医大学第一附属医院 A method for efficiently isolating adipose-derived adipose-derived mesenchymal stem cells
CN113215092A (en) * 2021-05-26 2021-08-06 山东博森医学工程技术有限公司 Rapid adipose-derived mesenchymal stem cell adipogenic differentiation method
CN113215092B (en) * 2021-05-26 2022-04-05 广州峰缘生物科技有限公司 Rapid adipose-derived mesenchymal stem cell adipogenic differentiation method

Also Published As

Publication number Publication date
CN102002478B (en) 2013-01-02

Similar Documents

Publication Publication Date Title
CN102002478A (en) Adipose-derived stem cell separation culture method
US9644182B2 (en) Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom
Qiao et al. Human mesenchymal stem cells isolated from the umbilical cord
CN103589683B (en) Separation method and culture method for umbilical cord mesenchymal stem cells
CN113692282B (en) Bioactive substance composition, serum-free medium containing composition and application of composition
Jiang et al. Nestin+ kidney resident mesenchymal stem cells for the treatment of acute kidney ischemia injury
WO2010065239A1 (en) Stem cells from urine and methods for using the same
WO2011111787A1 (en) Cell preparation containing mesenchymal stem cells, and method for producing same
CN102978156A (en) Expansion in vitro purification culture method of mesenchymal stem cells and culture medium
US20220395537A1 (en) Methods of stem cell culture for obtaining products, and implementations thereof
WO2012068710A1 (en) Methods for extracting mesenchymal stem cell from slight amount human adipose tissue and mass cultivation thereof
CN101821383A (en) A medium and method for in vitro large-scale culture of human adult primitive mesenchymal stem cells, and obtained primitive mesenchymal stem cells and applications thereof
CN105039248B (en) Tree shrew mesenchymal stem cell culture systems
CN103173407B (en) Method for induced differentiation of liver cells by using endometrium stem cells
KR101389849B1 (en) Method for culture of mesenchymal stem cell from gastrointestinal tissue, nerve tissue, or blood vessels and Uses Therefor
CN102140440A (en) Method for separating and culturing poultry bone mesenchymal stem cells by using bone marrow tissue block
CN101575590B (en) Preparation method of human umbilical cord mesenchymal stem cells
CN108138142A (en) Breeding is used in the interstital stem cell in transplanting(MSC)Method
CN115125192A (en) Bone marrow supernatant and application thereof in cell culture
CN101543644A (en) Constructing method of bracket-free engineering cartilaginous tissue and product thereof
Talakoob et al. Capability of cartilage extract to in vitro differentiation of rat mesenchymal stem cells (MSCs) to chondrocyte lineage
CN110628712B (en) Preparation methods and applications of therapeutic grade mesenchymal stem cells based on induced pluripotent stem cells
CN110484491B (en) Method for obtaining amniotic membrane and amniotic fluid derived endothelial progenitor cells and purification culture method thereof
CN113667635A (en) Xeno-free medium and method for amplifying mesenchymal stem cells using the same
Singh et al. In vitro Culture and Morphometry of Porcine Adipose Derived Mesenchymal Stem Cells (pAD-MSCs)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210412

Address after: No.11, 18 / F, building 9, No.399, Xiduan, Fucheng Avenue, Chengdu hi tech Zone, China (Sichuan) pilot Free Trade Zone, Chengdu, Sichuan 610000

Patentee after: Chengdu Lide enterprise management center (L.P.)

Address before: 610041 No. three, South Renmin Road, Sichuan, Chengdu Province 14

Patentee before: SICHUAN University

CP02 Change in the address of a patent holder
CP02 Change in the address of a patent holder

Address after: No.11, 18th floor, building 9, No.399, Fucheng avenue west section, Chengdu hi tech Zone, 610000 China (Sichuan) pilot Free Trade Zone, Chengdu, Sichuan Province

Patentee after: Chengdu Lide enterprise management center (L.P.)

Address before: No.11, 18 / F, building 9, No.399, Xiduan, Fucheng Avenue, Chengdu hi tech Zone, China (Sichuan) pilot Free Trade Zone, Chengdu, Sichuan 610000

Patentee before: Chengdu Lide enterprise management center (L.P.)

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20210628

Address after: 2-3 / F, building E7, No.16, hemin street, Chengdu hi tech Zone, China (Sichuan) pilot Free Trade Zone, Chengdu, Sichuan 610000

Patentee after: Chengdu worldlink Health Biotechnology Co.,Ltd.

Address before: No.11, 18th floor, building 9, No.399, west section of Fucheng Avenue, Chengdu hi tech Zone, China (Sichuan) pilot Free Trade Zone, Chengdu, Sichuan 610000

Patentee before: Chengdu Lide enterprise management center (L.P.)